
<!DOCTYPE publaw
  SYSTEM "cq-dscs-exchange-publaw.dtd">
<publaw bill-num="hr5860"
        congress="118"
        corrected-print="no"
        document-type="pl"
        pl-num="118-15"
        public-private="public"
        session="1"
        stat-page="71"
        stat-vol="137"
        version-date="20230930">
   
      
         Continuing Appropriations Act, 2024 and Other Extensions Act
      
   
   
      Public Law 118-15
      137 STAT. 71
      118th Congress
      September 30, 2023
      [H. R. 5860]
      AN ACT
      Making continuing appropriations for fiscal year 2024, and for other
            purposes.
   
   
      Be it enacted by the Senate and House of Representatives of the United
            States of America in Congress assembled,
      
         Continuing Appropriations Act, 2024 and Other Extensions Act.
      
      <section display-inline="no-display-inline"
               id="H49501788B2D2481DAF7C92C13C0132AC"
               qb-display-quote="yes"
               section-type="section-one">
         1.
         SHORT TITLE
         This Act may be cited as the <quote quote-display-end="auto"
                   quote-display-start="auto"
                   quote-type="text">
               Continuing Appropriations Act, 2024 and
                        Other Extensions Act
            .
         
            Animal Drug User Fee Amendments of 2023.
         
      
      <section display-inline="no-display-inline"
               id="H06ED9D773F984CFA995F67BF066A1E99"
               qb-display-quote="yes"
               section-type="subsequent-section">
         2.
         TABLE OF CONTENTS
         The table of contents of this Act is as
                follows:
         <toc container-level="legis-body-container"
              lowest-level="section"
              quoted-block="no-quoted-block"
              regeneration="no-regeneration">
            <toc-entry align="left"
                       bold="off"
                       idref="H49501788B2D2481DAF7C92C13C0132AC"
                       level="section">Sec. 1. Short title.
            <toc-entry align="left"
                       bold="off"
                       idref="H06ED9D773F984CFA995F67BF066A1E99"
                       level="section">Sec. 2. Table of contents.
            <toc-entry align="left"
                       bold="off"
                       idref="H32C0AF9879E94D34B8C85AFBA4CE6C5D"
                       level="section">Sec. 3. References.
            <toc-entry align="left"
                       bold="off"
                       idref="HD18AAD5F5DF84559B0AB4B286CF6A7A3"
                       level="division">Division A—Continuing Appropriations Act, 2024
            <toc-entry align="left"
                       bold="off"
                       idref="H0456D8CAD2334B3AA5276655AC42C224"
                       level="division">Division B—Other Matters
            <toc-entry align="left"
                       bold="off"
                       idref="H19094FF951E041F4926EB10F2324CB6B"
                       level="title">TITLE I—EXTENSIONS AND OTHER MATTERS
            <toc-entry align="left"
                       bold="off"
                       idref="H5188649ABDF34EF1AA687ECB09FE9950"
                       level="title">TITLE II—FAA EXTENSION
            <toc-entry align="left"
                       bold="off"
                       idref="H1CE22EE4B6EC4290841D2C0D85366E08"
                       level="title">TITLE III—HEALTH AND HUMAN SERVICES
            <toc-entry align="left"
                       bold="off"
                       idref="H95ADBBC7F730494986AA65D982E8555C"
                       level="title">TITLE IV—BUDGETARY EFFECTS
         
      
      <section display-inline="no-display-inline"
               id="H32C0AF9879E94D34B8C85AFBA4CE6C5D"
               qb-display-quote="yes"
               section-type="subsequent-section">
         3.
         REFERENCES
         Except as expressly provided otherwise, any
                reference to <quote quote-display-end="auto"
                   quote-display-start="auto"
                   quote-type="text">this Act contained in any division of this Act shall be
                treated as referring only to the provisions of that division.
         
            Applicability. Apportionments.
         
      
      
         A
         Continuing Appropriations Act, 2024
         <section display-inline="no-display-inline"
                  id="H2DD4F10800644409B73201C13AC07D40"
                  qb-display-quote="yes"
                  section-type="undesignated-section">
            The following sums are hereby appropriated, out of any money in the Treasury
                    not otherwise appropriated, and out of applicable corporate or other revenues,
                    receipts, and funds, for the several departments, agencies, corporations, and
                    other organizational units of Government for fiscal year 2024, and for other
                    purposes, namely:
         
         <section display-inline="no-display-inline"
                  id="H8A817243CF8C4177817E5B7AE620B167"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            101.
            Such amounts as may be necessary, at a rate for operations as provided in the
                    applicable appropriations Acts for fiscal year 2023 and under the authority and
                    conditions provided in such Acts, for continuing projects or activities
                    (including the costs of direct loans and loan guarantees) that are not otherwise
                    specifically provided for in this Act, that were conducted in fiscal year 2023,
                    and for which appropriations, funds, or other authority were made available in
                    the following appropriations Acts:
            <paragraph display-inline="no-display-inline"
                       id="H5B4CC771C54D42D2BBE1221D3B39924C"
                       qb-display-quote="yes">
               (1)
               The Agriculture, Rural Development, Food and Drug Administration, and
                        Related Agencies Appropriations Act, 2023 (division A of Public Law 117–328), except section
                        729, and 
                     137 STAT.
                                72
                   including the matter under the headings
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Food for Peace Title II Grants and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">McGovern-Dole
                            International Food for Education and Child Nutrition Program
                            Grants in title I of division M of Public Law 117–328, the matter under the headings
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Agricultural Research Service—Buildings and Facilities,
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Food Safety and Inspection Service, <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Rural Housing
                            Service— Rural Community Facilities Program Account (except all
                        that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">expended in such matter and except that
                        such matter shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$25,300,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$75,300,000), and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Rural Utilities Service—Rural
                            Water and Waste Disposal Program Account (except all that
                        follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">expended in such matter and except that such
                        matter shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$60,000,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$325,000,000) in title I of division N of Public Law 117–328, and section
                        2102 in title I of such division N.
            
            <paragraph display-inline="no-display-inline"
                       id="H790FDD13B72540B4A566BD5C10EC2CCA"
                       qb-display-quote="yes">
               (2)
               The Commerce, Justice, Science, and Related Agencies Appropriations Act,
                        2023 (division B of Public Law
                            117–328), except section 540, and except section 521(d)(1)
                        shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$122,572,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$705,768,000, and including the matter under the headings
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Federal Prison System—Buildings and Facilities and
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National Science Foundation—STEM Education (except all
                        that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">2024 in such matter and except that such
                        matter shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$92,000,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$217,000,000) in title II of division N of Public Law 117–328, and the second
                        paragraph under each of the headings <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National Oceanic and Atmospheric
                            Administration—Operations, Research, and Facilities (except all
                        that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">2024 in such paragraph and except that
                        such paragraph shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$42,000,000
                        for <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$62,000,000), <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National Oceanic and Atmospheric
                            Administration—Procurement, Acquisition and Construction,
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National Aeronautics and Space Administration—Construction and
                            Environmental Compliance and Restoration, and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National
                            Science Foundation—Research and Related Activities (except all
                        that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">2024 in such paragraph and except that
                        such paragraph shall be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$608,162,000
                        for <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$818,162,000) in title II of such division N.
               
                  Time periods.
               
            
            <paragraph display-inline="no-display-inline"
                       id="H0D92AA11177D4E0890843250FF20E750"
                       qb-display-quote="yes">
               (3)
               The Department of Defense Appropriations Act, 2023 (division C of Public Law 117–328).
            
            <paragraph display-inline="no-display-inline"
                       id="H98D3A0B1A62E4E8A83A56552EAD25868"
                       qb-display-quote="yes">
               (4)
               The Energy and Water Development and Related Agencies Appropriations Act,
                        2023 (division D of Public Law
                            117–328), except the first proviso under the heading <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">SPR
                            Petroleum Account, and except the second paragraph under the
                        heading <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Title 17 Innovative Technology Loan Guarantee
                        Program, and including the matter under the heading <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Energy
                            Programs—Nuclear Energy in title III of division M of Public Law 117–328 and the second
                        paragraph under each of the headings <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Corps of
                            Engineers—Civil—Department of the Army—Construction and
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Corps of Engineers—Civil—Department of the Army—Operation and
                            Maintenance in title IV of division N of Public Law 117–328.
            
            <paragraph display-inline="no-display-inline"
                       id="H42FE4DA7FFD34AF899BE5BE6DFE5BF21"
                       qb-display-quote="yes">
               (5)
               The Financial Services and General Government Appropriations Act, 2023
                        (division E of Public Law
                            117–328).
            
            <paragraph display-inline="no-display-inline"
                       id="H819C459FF64546409DFA876794976963"
                       qb-display-quote="yes">
               (6)
               The Department of Homeland Security Appropriations Act, 2023 (division F
                        of Public Law 117–328), section
                        2602 
                     137 STAT.
                            73
                   of title VI of division N of Public Law 117–328, and title III
                        of division O of Public Law
                            117–328.
            
            <paragraph display-inline="no-display-inline"
                       id="H6BC3389FBF8E4730B292B09E29315EF8"
                       qb-display-quote="yes">
               (7)
               The Department of the Interior, Environment, and Related Agencies
                        Appropriations Act, 2023 (division G of Public Law 117–328), except section 443, and including the
                        second paragraph under each of the headings <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Department of the
                            Interior—Departmental Offices—Department-Wide Programs—Wildland Fire
                            Management and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Related Agencies—Department of
                            Agriculture—Forest Service—Wildland Fire Management in title VII
                        of division N of Public Law
                            117–328.
            
            <paragraph display-inline="no-display-inline"
                       id="H4FF9497AB48F4E30A1AB709DDACA91F8"
                       qb-display-quote="yes">
               (8)
               The Departments of Labor, Health and Human Services, and Education, and
                        Related Agencies Appropriations Act, 2023 (division H of Public Law 117–328), section 145 of
                        division A of Public Law
                            117–180, and the second paragraph under the heading
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Administration for Children and Families—Low Income Home Energy
                            Assistance in title VIII of division N of Public Law 117–328.
            
            <paragraph display-inline="no-display-inline"
                       id="H78D52B44F12846F78A693AD951020205"
                       qb-display-quote="yes">
               (9)
               The Legislative Branch Appropriations Act, 2023 (division I of Public Law 117–328), and section 6
                        in the matter preceding division A of Public Law 117–328.
            
            <paragraph display-inline="no-display-inline"
                       id="H7AEFA95FB01E4CA4A1EBC12C1E589157"
                       qb-display-quote="yes">
               (10)
               The Military Construction, Veterans Affairs, and Related Agencies
                        Appropriations Act, 2023 (division J of Public Law 117–328).
            
            <paragraph display-inline="no-display-inline"
                       id="H8437835BAC6F42229CC081EA7E6A9A03"
                       qb-display-quote="yes">
               (11)
               The Department of State, Foreign Operations, and Related Programs
                        Appropriations Act, 2023 (division K of Public Law 117–328), except section 7069, and including the
                        matter under the headings <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Department of State—Administration of
                            Foreign Affairs—Diplomatic Programs (except all that follows
                        after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">2024 in such matter and except that such matter shall
                        be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$87,054,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$147,054,000), <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Bilateral Economic Assistance—Funds
                            Appropriated to the President—International Disaster Assistance
                        (except all that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">expended in such matter and
                        except that such matter shall be applied by substituting
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$637,902,000 for <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$937,902,000),
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Bilateral Economic Assistance—Funds Appropriated to the
                            President—Assistance for Europe, Eurasia and Central Asia,
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Bilateral Economic Assistance—Department of State—Migration and
                            Refugee Assistance (except all that follows after
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">expended in such matter and except that such matter shall
                        be applied by substituting <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$915,048,000 for
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$1,535,048,000), and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">International Security
                            Assistance—Department of State—International Narcotics Control and Law
                            Enforcement (except all that follows after <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">2024
                        in such matter and except that such matter shall be applied by substituting
                            <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$74,996,000 for <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">$374,996,000) in title VII
                        of division M of Public Law
                            117–328. 
            
            <paragraph display-inline="no-display-inline"
                       id="HF0E539885D8645DB8F630E31A17E232B"
                       qb-display-quote="yes">
               (12)
               The Transportation, Housing and Urban Development, and Related Agencies
                        Appropriations Act, 2023 (division L of Public Law 117–328), except sections 153 and 420, and
                        including the matter under the headings <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Public and Indian Housing—
                            Tenant-Based Rental Assistance and <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Housing
                            Programs—Project-Based Rental Assistance in title X of division
                        N of Public Law 117–328.
            
         
         <section display-inline="no-display-inline"
                  id="H4B32DA9CDE5A424BB3E190C392109424"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            102.
            <subsection display-inline="no-display-inline"
                        id="HD6042712AB0848FEAA893A82DC818E4E"
                        qb-display-quote="yes">
               (a)
               No appropriation or funds made available or authority granted pursuant to
                        section 101 for the Department of Defense shall be used for:
                                
                     137 STAT.
                                74
                  
               
               <paragraph display-inline="no-display-inline"
                          id="H73DF725E7ECD48D3A252FA09C9B56E48"
                          qb-display-quote="yes">
                  (1)
                  the new production of items not funded for production in fiscal year
                            2023 or prior years;
               
               <paragraph display-inline="no-display-inline"
                          id="H7C5376D7F4754E4CADC79C2E2D990A5E"
                          qb-display-quote="yes">
                  (2)
                  the increase in production rates above those sustained with fiscal
                            year 2023 funds; or
               
               <paragraph display-inline="no-display-inline"
                          id="H6770FD54D64A493F85961C8241B65909"
                          qb-display-quote="yes">
                  (3)
                  the initiation, resumption, or continuation of any project, activity,
                            operation, or organization (defined as any project, subproject,
                            activity, budget activity, program element, and subprogram within a
                            program element, and for any investment items defined as a P–1 line item
                            in a budget activity within an appropriation account and an R–1 line
                            item that includes a program element and subprogram element within an
                            appropriation account) for which appropriations, funds, or other
                            authority were not available during fiscal year 2023. 
               
            
            <subsection display-inline="no-display-inline"
                        id="HB9932559DF7F447ABC1B30D1E404F65C"
                        qb-display-quote="yes">
               (b)
               No appropriation or funds made available or authority granted pursuant to
                        section 101 for the Department of Defense shall be used to initiate
                        multi-year procurements utilizing advance procurement funding for economic
                        order quantity procurement unless specifically appropriated later. 
            
         
         <section display-inline="no-display-inline"
                  id="HE6E118449A4148FB81E3EEAAD3E69785"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            103.
            Appropriations made by section 101 shall be available to the extent and in the
                    manner that would be provided by the pertinent appropriations Act. 
         
         <section display-inline="no-display-inline"
                  id="H09F05A45C8A24A53BD48344D3A21A3EA"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            104.
            Except as otherwise provided in section 102, no appropriation or funds made
                    available or authority granted pursuant to section 101 shall be used to initiate
                    or resume any project or activity for which appropriations, funds, or other
                    authority were not available during fiscal year 2023. 
         
         <section display-inline="no-display-inline"
                  id="H95B2DE6B9A41479CB6C46105EC85B034"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            105.
            Appropriations made and authority granted pursuant to this Act shall cover all
                    obligations or expenditures incurred for any project or activity during the
                    period for which funds or authority for such project or activity are available
                    under this Act. 
         
         <section display-inline="no-display-inline"
                  id="H2170B2BAEE9346FBB623F5826316CD98"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            106.
            Unless otherwise provided for in this Act or in the applicable appropriations
                    Act for fiscal year 2024, appropriations and funds made available and authority
                    granted pursuant to this Act shall be available until whichever of the following
                    first occurs:
            <paragraph display-inline="no-display-inline"
                       id="HD129A7F462FE4D6F99A2D505B52E435D"
                       qb-display-quote="yes">
               (1)
               The enactment into law of an appropriation for any project or activity
                        provided for in this Act.
            
            <paragraph display-inline="no-display-inline"
                       id="HF69C99A1522446FE856E144C2409EC2E"
                       qb-display-quote="yes">
               (2)
               The enactment into law of the applicable appropriations Act for fiscal
                        year 2024 without any provision for such project or activity.
            
            <paragraph display-inline="no-display-inline"
                       id="H632E7C1CF75C43538642C48937422D17"
                       qb-display-quote="yes">
               (3)
               November 17, 2023.
               
                  Expiration date.
               
            
         
         <section display-inline="no-display-inline"
                  id="H70967CCA31014AAC8890B5E70255B099"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            107.
            Expenditures made pursuant to this Act shall be charged to the applicable
                    appropriation, fund, or authorization whenever a bill in which such applicable
                    appropriation, fund, or authorization is contained is enacted into law.
         
         <section display-inline="no-display-inline"
                  id="H34DA7077EFD54BB3B5B4433D76FB69AD"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            108.
            Appropriations made and funds made available by or authority granted pursuant
                    to this Act may be used without regard to the time limitations for submission
                    and approval of apportionments set forth in section 1513 of title 31, United
                    States Code, but nothing in this Act may be construed to waive any other
                    provision of law governing the apportionment of funds. 
         
         <section display-inline="no-display-inline"
                  id="HC71AAC98ED554171B97B3F11C73A28FF"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            109.
            Notwithstanding any other provision of this Act, except section 106, for those
                    programs that would otherwise have high initial rates of operation or complete
                    distribution of appropriations at the beginning of fiscal year 2024 because of
                    distributions of funding to States, foreign countries, grantees, or others, such
                    high initial rates of operation or complete distribution shall not
                            
                  137 STAT.
                        75
                be made, and no grants shall be awarded for such
                    programs funded by this Act that would impinge on final funding prerogatives.
                
         
         <section display-inline="no-display-inline"
                  id="H9A95BB40A535411FBCBF0D2980EF3375"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            110.
            This Act shall be implemented so that only the most limited funding action of
                    that permitted in the Act shall be taken in order to provide for continuation of
                    projects and activities. 
         
         <section display-inline="no-display-inline"
                  id="H721E279B97ED400394BF2C834719E6DC"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            111.
            <subsection display-inline="no-display-inline"
                        id="H4D2E729DD3C04F6391102BFA963B0179"
                        qb-display-quote="yes">
               (a)
               For entitlements and other mandatory payments whose budget authority was
                        provided in appropriations Acts for fiscal year 2023, except the matter
                        under the heading <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">Cost of War Toxic Exposures Fund in title
                        II of division J of Public Law
                            117–328, and for activities under the Food and Nutrition Act of
                        2008, activities shall be continued at the rate to maintain program levels
                        under current law, under the authority and conditions provided in the
                        applicable appropriations Act for fiscal year 2023, to be continued through
                        the date specified in section 106(3).
               
                  Extensions.
               
            
            <subsection display-inline="no-display-inline"
                        id="H856093FCF2A44369AE24A25B78669701"
                        qb-display-quote="yes">
               (b)
               Notwithstanding section 106, obligations for mandatory payments due on or
                        about the first day of any month that begins after October 2023 but not
                        later than 30 days after the date specified in section 106(3) may continue
                        to be made, and funds shall be available for such payments.
               
                  Deadline.
               
            
         
         <section display-inline="no-display-inline"
                  id="H6ECDE2109CBA4477BD7FF4823ACE0F6E"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            112.
            Amounts made available under section 101 for civilian personnel compensation
                    and benefits in each department and agency may be apportioned up to the rate for
                    operations necessary to avoid furloughs within such department or agency,
                    consistent with the applicable appropriations Act for fiscal year 2023, except
                    that such authority provided under this section shall not be used until after
                    the department or agency has taken all necessary actions to reduce or defer
                    non-personnel-related administrative expenses.
         
         <section display-inline="no-display-inline"
                  id="HA2B2CB466C8C487BACA804A09F12645F"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            113.
            Funds appropriated by this Act may be obligated and expended notwithstanding
                    section 10 of Public Law 91–672
                        (22 U.S.C. 2412),
                    section 15 of the State Department Basic Authorities Act of 1956 (22 U.S.C. 2680), section 313
                    of the Foreign Relations Authorization Act, Fiscal Years 1994 and 1995 (22 U.S.C. 6212), and section
                    504(a)(1) of the National Security Act of 1947 (50 U.S.C. 3094(a)(1)).
         
         <section display-inline="no-display-inline"
                  id="H9A4ACD16838A4707B6A2B826C210F724"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            114.
            <subsection display-inline="no-display-inline"
                        id="HD377EB0463CB496FAEB8BB7D110DFBB2"
                        qb-display-quote="yes">
               (a)
               <paragraph display-inline="no-display-inline"
                          id="H3CC4D3116B984FCE9CBFAEE8950D75C7"
                          qb-display-quote="yes">
                  (1)
                  For each amount incorporated by reference in this Act from amounts
                            provided by division M or N of Public Law 117–328, each section or paragraph of an
                            account providing each such amount, as applicable, shall be applied as
                            if that section or paragraph ended with the following sentence:
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">The amount provided herein is designated by the Congress as
                                an emergency requirement pursuant to section 251(b)(2)(A)(i) of the
                                Balanced Budget and Emergency Deficit Control Act of 1985..
                        
               
               <paragraph display-inline="no-display-inline"
                          id="HFAA74EDF1CDF43D2A5601F79857585CA"
                          indent="subsection"
                          qb-display-quote="yes">
                  (2)
                  Each amount incorporated by reference in this Act that was previously
                            designated by the Congress as an emergency requirement pursuant to
                            section 4001(a)(1) of S. Con. Res. 14 (117th Congress), the concurrent
                            resolution on the budget for fiscal year 2022, and section 1(e) of H.
                            Res. 1151 (117th Congress), as engrossed in the House of Representatives
                            on June 8, 2022, or as being for disaster relief pursuant to a
                            concurrent resolution on the budget in the Senate and section 1(f) of H.
                            Res. 1151 (117th Congress), as engrossed in the House of Representatives
                            on June 8, 2022, is designated by the Congress as being an emergency
                            requirement pursuant to section 251(b)(2)(A)(i) of the Balanced Budget
                            and Emergency Deficit Control Act of 1985 or as being for disaster
                            relief pursuant to section 251(b)(2)(D) of such Act,
                            respectively.
                  
                     137 STAT. 76
                  
               
            
            <subsection display-inline="no-display-inline"
                        id="H443AC4C8FE894FBE90E6639253363F09"
                        indent="subsection"
                        qb-display-quote="yes">
               (b)
               <paragraph display-inline="no-display-inline"
                          id="H1445A2CB9AB84B56A772B37AA084AF44"
                          qb-display-quote="yes">
                  (1)
                  Each amount incorporated by reference in this Act that was specified
                            to meet the terms of section 4004(b)(5)(B) of S. Con. Res. 14 (117th
                            Congress), the concurrent resolution on the budget for fiscal year 2022,
                            and section 1(g)(2) of H. Res. 1151 (117th Congress), as engrossed in
                            the House of Representatives on June 8, 2022, or as additional new
                            budget authority for purposes of section 4004(b)(5) of such concurrent
                            resolution and section 1(g) of such House resolution, is provided to
                            meet the terms of section 251(b)(2)(F)(ii)(I) of the Balanced Budget and
                            Emergency Deficit Control Act of 1985, or is additional new budget
                            authority as specified for purposes of section 251(b)(2)(F) of such Act,
                            respectively.
               
               <paragraph display-inline="no-display-inline"
                          id="HCBC2249E5F32408C90B35E5C87201FE0"
                          indent="paragraph"
                          qb-display-quote="yes">
                  (2)
                  Each amount incorporated by reference in this Act for
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">Department of Labor—Employment and Training
                                Administration—State Unemployment Insurance and Employment Service
                                Operations that was specified to meet the terms of a
                            concurrent resolution on the budget in the Senate and section 1(j)(2) of
                            H. Res. 1151 (117th Congress), as engrossed in the House of
                            Representatives on June 8, 2022, or as additional new budget authority
                            for purposes of a concurrent resolution on the budget in the Senate and
                            section 1(j) of such House resolution, is provided to meet the terms of
                            section 251(b)(2)(E)(ii) of the Balanced Budget and Emergency Deficit
                            Control Act of 1985, or is additional new budget authority as specified
                            for the purposes of section 251(b)(2)(E) of such Act,
                            respectively.
               
               <paragraph display-inline="no-display-inline"
                          id="HA1A79E4DF0954C46977E09CFF3662046"
                          indent="paragraph"
                          qb-display-quote="yes">
                  (3)
                  Each amount incorporated by reference in this Act for
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">Department of Health and Human Services— Centers for Medicare
                                &amp;amp; Medicaid Services—Health Care Fraud and Abuse Control
                                Account that was specified to meet the terms of a concurrent
                            resolution on the budget in the Senate, or as additional new budget
                            authority for purposes of a concurrent resolution on the budget in the
                            Senate and section 1(h) of H. Res. 1151 (117th Congress), as engrossed
                            in the House of Representatives on June 8, 2022, is provided to meet the
                            terms of section 251(b)(2)(C)(ii) of the Balanced Budget and Emergency
                            Deficit Control Act of 1985, or is additional new budget authority as
                            specified for the purposes of section 251(b)(2)(C) of such Act,
                            respectively.
               
               <paragraph display-inline="no-display-inline"
                          id="HBBBF8185DADA40BDB87EA12FB9982BC7"
                          indent="paragraph"
                          qb-display-quote="yes">
                  (4)
                  Each amount incorporated by reference in this Act for <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">Social
                                Security Administration—Limitation on Administrative
                                Expenses that was specified to meet the terms of a
                            concurrent resolution on the budget in the Senate, or as additional new
                            budget authority for purposes of a concurrent resolution on the budget
                            in the Senate and section 1(i) of H. Res. 1151 (117th Congress), as
                            engrossed in the House of Representatives on June 8, 2022, is provided
                            to meet the terms of section 251(b)(2)(B)(ii)(III) of the Balanced
                            Budget and Emergency Deficit Control Act of 1985, or is additional new
                            budget authority as specified for the purposes of section 251(b)(2)(B)
                            of such Act, respectively. 
               
            
            <subsection display-inline="no-display-inline"
                        id="H59065F3064854F83A662B3C69B225081"
                        qb-display-quote="yes">
               (c)
               Each amount designated in this Act by the Congress as an emergency
                        requirement pursuant to section 251(b)(2)(A)(i) of the Balanced Budget and
                        Emergency Deficit Control Act of 1985 shall be available (or repurposed or
                        rescinded, if applicable) only if the President subsequently so designates
                        all such amounts and transmits such designations to the Congress.
               
                  President.
               
            
         
         <section display-inline="no-display-inline"
                  id="HC38D6946CE6944D28B7B3E48D5776E53"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            115.
            <subsection display-inline="no-display-inline"
                        id="H61C9334F4DE2459F8121BBC7C7C7E15F"
                        qb-display-quote="yes">
               (a)
               Rescissions or cancellations of discretionary budget authority that
                        continue pursuant to section 101 in Treasury Appropriations Fund Symbols
                        (TAFS)— 
                     137 STAT.
                                77
                  
               
               
                  Rescissions.
               
               <paragraph display-inline="no-display-inline"
                          id="HAA85B9B6F56046FCA47027748845089C"
                          qb-display-quote="yes">
                  (1)
                  to which other appropriations are not provided by this Act, but for
                            which there is a current applicable TAFS that does receive an
                            appropriation in this Act; or
               
               <paragraph display-inline="no-display-inline"
                          id="HC4D29D2A6AF3415485B4D8D5F35DB694"
                          qb-display-quote="yes">
                  (2)
                  which are no-year TAFS and receive other appropriations in this Act,
                            may be continued instead by reducing the rate for operations otherwise
                            provided by section 101 for such current applicable TAFS, as long as
                            doing so does not impinge on the final funding prerogatives of the
                            Congress.
                  
                     Extension.
                  
               
            
            <subsection display-inline="no-display-inline"
                        id="HFDC3D0B9C74C4342834090EC3BC0E709"
                        qb-display-quote="yes">
               (b)
               Rescissions or cancellations described in subsection (a) shall continue in
                        an amount equal to the lesser of—
               
                  Extension.
               
               <paragraph display-inline="no-display-inline"
                          id="HC38B69177ACA479DA40180A70B988C38"
                          qb-display-quote="yes">
                  (1)
                  the amount specified for rescission or cancellation in the applicable
                            appropriations Act referenced in section 101 of this Act; or
               
               <paragraph display-inline="no-display-inline"
                          id="HBD06947AE1BA4CB7896D86FCB960FB42"
                          qb-display-quote="yes">
                  (2)
                  the amount of balances available, as of October 1, 2023, from the
                            funds specified for rescission or cancellation in the applicable
                            appropriations Act referenced in section 101 of this Act.
                  
                     Effective date.
                  
               
            
            <subsection display-inline="no-display-inline"
                        id="H49AB166EC34B4C29B4747F784AF582A4"
                        qb-display-quote="yes">
               (c)
               No later than November 17, 2023, the Director of the Office of Management
                        and Budget shall provide to the Committees on Appropriations of the House of
                        Representatives and the Senate a comprehensive list of the rescissions or
                        cancellations that will continue pursuant to section 101:
                            Provided, That the information in such comprehensive
                        list shall be periodically updated to reflect any subsequent changes in the
                        amount of balances available, as of October 1, 2023, from the funds
                        specified for rescission or cancellation in the applicable appropriations
                        Act referenced in section 101, and such updates shall be transmitted to the
                        Committees on Appropriations of the House of Representatives and the Senate
                        upon request.
               
                  Deadline. List.
               
               
                  Updates. Effective date.
               
            
         
         <section display-inline="no-display-inline"
                  id="H1E7C4DC8F3824D4ABBC1FD7AA7FC29C8"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            116.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Farm Service
                        Agency—Agricultural Credit Insurance Fund Program Account may be
                    apportioned up to the rate for operations necessary to accommodate approved
                    applications for direct and guaranteed farm ownership loans, as authorized by
                        7 U.S.C. 1922 et seq.
            
         
         <section display-inline="no-display-inline"
                  id="HD5A6DAE416B34FE68B487AA2D99F5931"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            117.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Rural Housing Service—Rental
                        Assistance Program may be apportioned up to the rate for operations
                    necessary to maintain activities as authorized by section 521(a)(2) of the
                    Housing Act of 1949.
         
         <section display-inline="no-display-inline"
                  id="HB4CCF5FC65234FB98266AF8ED2CA58EF"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            118.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Domestic Food Programs—Food
                        and Nutrition Service—Special Supplemental Nutrition Program for Women,
                        Infants, and Children (WIC) may be apportioned at the rate for
                    operations necessary to maintain participation.
         
         <section display-inline="no-display-inline"
                  id="H0ABC456B456C4C5D80CF12E9A310046D"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            119.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Domestic Food Programs—Food
                        and Nutrition Service—Commodity Assistance Program may be
                    apportioned up to the rate for operations necessary to maintain current program
                    caseload in the Commodity Supplemental Food Program.
         
         <section display-inline="no-display-inline"
                  id="H184AD33797864AB894E17AA67C37AB7B"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            120.
            Section 260 of the Agricultural Marketing Act of 1946 (7 U.S.C. 1636i) and section 942 of the
                    Livestock Mandatory Reporting Act of 1999 (7 U.S.C. 1635 note; Public Law 106–78) shall be applied by substituting the date
                    specified in section 106(3) of this Act for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">September 30,
                    2023.
         
         <section display-inline="no-display-inline"
                  id="H7C5458507FC84325869D6B76EFEDAB86"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            121.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">National Telecommunications
                        and Information Administration—Salaries and Expenses may be
                    apportioned up to the rate for operations necessary to administer broadband
                    programs.
            
               137 STAT. 78
            
         
         <section display-inline="no-display-inline"
                  id="H78E6CB5759DC4F6699FD1B66A659EA91"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            122.
            <subsection display-inline="no-display-inline"
                        id="HDEDED02ECC6E484BA4E91B69A35D8A90"
                        qb-display-quote="yes">
               (a)
               Funds previously made available in the Consolidated Appropriations Act,
                        2017 (Public Law 115–31) and the
                        Consolidated Appropriations Act, 2018 (Public Law 115–141) under the heading <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">National
                            Aeronautics and Space Administration—Space Operations that were
                        available for obligation through fiscal year 2018 and fiscal year 2019,
                        respectively, are to remain available through fiscal year 2024 for the
                        liquidation of valid obligations incurred in fiscal years 2017 through
                        2019.
            
            <subsection display-inline="no-display-inline"
                        id="HC9A4593BD6EE41059DF00F4B13232DE4"
                        qb-display-quote="yes">
               (b)
               <paragraph display-inline="no-display-inline"
                          id="HE53A587C6C0C4ECB80C215746A52C7C2"
                          qb-display-quote="yes">
                  (1)
                  Subject to paragraph (2), this section shall become effective
                            immediately upon enactment of this Act.
                  
                     Effective date.
                  
                  
                     Effective date.
                  
               
               <paragraph display-inline="no-display-inline"
                          id="H2A6FB2951C9D4E18A77A23FAFD137592"
                          indent="subsection"
                          qb-display-quote="yes">
                  (2)
                  If this Act is enacted after September 30, 2023, this section shall be
                            applied as if it were in effect on September 30, 2023. 
               
            
         
         <section display-inline="no-display-inline"
                  id="HC913FAA3BA7143C5B3873C583A381D5F"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            123.
            For purposes of section 235(b) of the Sentencing Reform Act of 1984 (18 U.S.C. 3551 note; Public Law 98–473; 98 Stat. 2032), as
                    such section relates to chapter
                        311 of title 18, United States Code, and the United States Parole
                    Commission, each reference in such section to <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">36 years or
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">36-year period shall be deemed a reference to <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">36 years
                        and 17 days or <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">36-year and 17-day period,
                    respectively.
         
         <section display-inline="no-display-inline"
                  id="H2548C15C1FBD42309D94C7A9AFF43483"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            124.
            Notwithstanding sections 102 and 104, amounts made available by section 101 to
                    the Department of Defense for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Shipbuilding and Conversion, Navy
                    may be apportioned up to the rate for operations necessary for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Ohio
                        Replacement Submarine (Full Funding) in an amount not to exceed
                    $621,270,000 for the procurement of one Columbia Class Submarine.
         
         <section display-inline="no-display-inline"
                  id="H6A90F5437ED24E6AAEBDDEDD4060B53A"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            125.
            During the period covered by this Act, section 714(b)(2)(B) of title 10,
                    United States Code, shall be applied by substituting <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">four years
                    for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">two years.
         
         <section display-inline="no-display-inline"
                  id="H504861E243F64C009C5EFA891E531006"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            126.
            Notwithstanding section 101, the matter preceding the first proviso under the
                    heading <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Office of Personnel Management—Salaries and Expenses in
                    division E of Public Law 117–328
                    shall be applied by substituting <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$219,076,000 for
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$190,784,000.
         
         <section display-inline="no-display-inline"
                  id="HD31570E3E7444CABBF27EDB42712BC4C"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            127.
            Notwithstanding any other provision of this Act, except section 106, the
                    District of Columbia may expend local funds made available under the heading
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">District of Columbia—District of Columbia Funds for such
                    programs and activities under the District of Columbia Appropriations Act, 2023
                    (title IV of division E of Public Law
                        117–328) at the rate set forth in the Fiscal Year 2024 Local Budget
                    Act of 2023 (D.C. Act 25–161), as modified as of the date of enactment of this
                    Act.
         
         <section display-inline="no-display-inline"
                  id="H2F4516F894954E38BA9873A9FC54A5F9"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            128.
            Amounts made available by section 101 to the Department of Homeland Security
                    under the heading <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Federal Emergency Management Agency—Disaster Relief
                        Fund may be apportioned up to the rate for operations necessary to
                    carry out response and recovery activities under the Robert T. Stafford Disaster
                    Relief and Emergency Assistance Act (42 U.S.C. 5121 et seq.).
         
         <section display-inline="no-display-inline"
                  id="HEF17C66197994F599BB7FCED74E7A20F"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            129.
            In addition to amounts otherwise provided by section 101, for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Federal
                        Emergency Management Agency—Disaster Relief Fund, there is
                    appropriated $16,000,000,000, for an additional amount for fiscal year 2024, to
                    remain available until expended, of which $2,000,000 shall be transferred to
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Office of the Inspector General—Operations and Support for
                    audits and investigations of activities funded under <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Federal Emergency
                        Management Agency—Disaster Relief Fund and $15,500,000,000 shall be
                    for major disasters declared pursuant to the Robert T. Stafford Disaster Relief
                    and Emergency Assistance Act 
                    (42
                        U.S.C. 5121 et seq.): Provided,
                    That such amount is designated by the Congress as being for an emergency
                    requirement pursuant to section 251(b)(2)(A)(i) of the Balanced Budget and
                    Emergency Deficit Control Act of 1985.
            
               Transfer authority.
            
         
         <section display-inline="no-display-inline"
                  id="HD8B8B2A2D4844775BF5B3741F27DADA2"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            130.
            <subsection display-inline="no-display-inline"
                        id="H82BF63AABA884B9E99F05B5B794096CD"
                        qb-display-quote="yes">
               (a)
               Sections 1309(a) and 1319 of the National Flood Insurance Act of 1968
                            (42 U.S.C.
                            4016(a) and 4026) shall be applied by substituting the date
                        specified in section 106(3) of this Act for <quote quote-display-end="auto"
                         quote-display-start="auto"
                         quote-type="text">September 30,
                            2023.
            
            <subsection display-inline="no-display-inline"
                        id="HBCCDB979AFD142C2889AA654A84967C5"
                        qb-display-quote="yes">
               (b)
               <paragraph display-inline="no-display-inline"
                          id="H90816A5B3E4441349C46CE1826D13F44"
                          qb-display-quote="yes">
                  (1)
                  Subject to paragraph (2), this section shall become effective
                            immediately upon enactment of this Act.
               
               <paragraph display-inline="no-display-inline"
                          id="HE50E54587604492CB2E673D75A783A63"
                          indent="subsection"
                          qb-display-quote="yes">
                  (2)
                  If this Act is enacted after September 30, 2023, this section shall be
                            applied as if it were in effect on September 30, 2023.
               
            
         
         <section display-inline="no-display-inline"
                  id="H9119F22A31554840AB2B2E928BB9C7C2"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            131.
            Section 227(a) of the Federal Cybersecurity Enhancement Act of 2015 (6 U.S.C. 1525(a)) shall be
                    applied by substituting the date specified in section 106(3) of this Act for
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">September 30, 2023.
         
         <section display-inline="no-display-inline"
                  id="HFF3A491296F3410E86D52FCE83DFB6F2"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            132.
            Amounts made available by section 101 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Department of the
                        Interior—Department-Wide Programs—Wildland Fire Management and
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Department of Agriculture—Forest Service—Wildland Fire
                        Management shall be available for the Federal wildland firefighter
                    base salary increase provided under section 40803(d)(4)(B) of Public Law 117–58 and may be apportioned
                    up to the rate for operations necessary to continue to fund such base salary
                    increase.
         
         <section display-inline="no-display-inline"
                  id="HD621CFE43C3A42B89F0B8D0B26E70E37"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            133.
            Activities authorized by part A of title IV (other than under section 403(c)
                    or 418) and section 1108(b) of the Social Security Act shall continue through
                    the date specified in section 106(3), in the manner authorized for fiscal year
                    2023, and out of any money in the Treasury of the United States not otherwise
                    appropriated, there are hereby appropriated such sums as may be necessary for
                    such purpose.
            
               Extension.
            
            
               Time periods.
            
         
         <section display-inline="no-display-inline"
                  id="H9936CEB0A9204844BC9F63B6A3A1375F"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            134.
            Notwithstanding section 101, section 126 of division J of Public Law 117–328 shall be applied
                    during the period covered by this Act by substituting <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">fiscal year 2017,
                        fiscal year 2018, and fiscal year 2019 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">fiscal year 2017
                        and fiscal year 2018.
         
         <section display-inline="no-display-inline"
                  id="HFC7C64F55D144434B6E849B9F17558E5"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            135.
            The authority provided by section 2401 of the Afghanistan Supplemental
                    Appropriations Act, 2022 (division C of Public Law 117–43) shall continue in effect through the date
                    specified in section 106(3) of this Act.
            
               Extension.
            
         
         <section display-inline="no-display-inline"
                  id="HE2690B0DE26B4417888FF1A23687B3E1"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            136.
            Notwithstanding section 101, the matter under the heading <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Bilateral
                        Economic Assistance—Independent Agencies—Millennium Challenge
                        Corporation in title III of division K of Public Law 117–328 shall be applied by inserting the
                    following new provisos before the last proviso: <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">
                  Provided further, That the member of the Board described in
                        section 604(c)(3)(B)(ii) of the Millennium Challenge Act of 2003, as amended
                            (22 U.S.C.
                            7703(c)(3)(B)(ii)), whose term began on September 16, 2019,
                        shall continue to serve in such appointment until March 31, 2024:
                            Provided further, That in the event that a new member
                        of the Board described in section 604(c)(3)(B) of such Act (22 U.S.C. 7703(c)(3)(B))
                        is appointed prior to March 31, 2024, the term of the member of the Board
                        whose term began on September 16, 2019, shall terminate as of the date of
                        such appointment:.
            
               Termination date.
            
            
               Termination date.
            
         
         <section display-inline="no-display-inline"
                  id="H084E3AE96E2F460D95862CB8E0E9F8D8"
                  qb-display-quote="yes"
                  section-type="subsequent-section">
            137.
            Notwithstanding section 101, the matter preceding the first proviso under the
                    heading <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">Department of Transportation—Federal Aviation
                        Administration—Facilities and Equipment in title
                            
                  137 STAT.
                        80
                I of division L of Public Law 117–328 shall be applied by substituting
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$617,000,000 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$570,000,000 and substituting
                        <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$2,174,200,000 for <quote quote-display-end="auto"
                      quote-display-start="auto"
                      quote-type="text">$2,221,200,000.
         
      
      
         B
         Other Matters
         <title id="H19094FF951E041F4926EB10F2324CB6B"
                qb-display-quote="yes"
                style="OLC">
            I
            EXTENSIONS AND OTHER MATTERS
            <section display-inline="no-display-inline"
                     id="H7DD4E619E09F47D8B60451B14B20FD0E"
                     qb-display-quote="yes"
                     section-type="subsequent-section">
               2101.
               EXTENSION OF CERTAIN PROVISIONS OF THE COMPACT OF FREE ASSOCIATION WITH
                        THE FEDERATED STATES OF MICRONESIA AND THE FEDERAL PROGRAM AND SERVICES
                        AGREEMENTS WITH THE FEDERATED STATES OF MICRONESIA AND THE REPUBLIC OF THE
                        MARSHALL ISLANDS
               
                  Time periods.
               
               <subsection display-inline="no-display-inline"
                           id="H984D56EDB2C4495C80FF9CBA4C195D9C"
                           qb-display-quote="yes">
                  (a)
                  Grant and other financial assistance
                  <paragraph display-inline="no-display-inline"
                             id="H48D6705DCAC94226AEDF72CE2E808EEB"
                             qb-display-quote="yes">
                     (1)
                     In general
                     During the period beginning on October 1, 2023, and ending on
                                November 17, 2023, any activities described in sections 211, 212,
                                and 215 of the Compact of Free Association between the Government of
                                the United States of America and the Government of the Federated
                                States of Micronesia set forth in section 201(a) of the Compact of
                                Free Association Amendments Act of 2003 (48 U.S.C. 1921 note; Public Law 108–188) shall,
                                with the mutual consent of the Federated States of Micronesia,
                                continue in the manner authorized and required for fiscal year 2023
                                under the agreements described in paragraphs (4) and (5) of section
                                462(b) of that Compact.
                  
                  <paragraph display-inline="no-display-inline"
                             id="H07BC6751ED8741FAB6AF4792EE6125E6"
                             qb-display-quote="yes">
                     (2)
                     Funding
                     There is appropriated, out of any money in the Treasury not
                                otherwise appropriated, to carry out the activities authorized under
                                paragraph (1) an amount equal to the pro rata portion of the amount
                                appropriated for those activities for fiscal year 2023.
                  
               
               <subsection display-inline="no-display-inline"
                           id="HA8C2388997CE4F4F9A6EE7A9670FE070"
                           qb-display-quote="yes">
                  (b)
                  Federal programs and services
                  
                     48 USC 1921 note.
                  
                  During the period beginning on October 1, 2023, and ending on the date
                            on which a new Federal programs and services agreement with the
                            applicable country enters into force, any activities described in
                            sections 131, 132, and 221(a) of the Compact of Free Association between
                            the Government of the United States of America and the Government of the
                            Federated States of Micronesia set forth in section 201(a) of the
                            Compact of Free Association Amendments Act of 2003 (48 U.S.C. 1921 note; Public Law 108–188) and
                            sections 131, 132, and 221(a) of the Compact of Free Association between
                            the Government of the United States of America and the Government of the
                            Republic of the Marshall Islands set forth in section 201(b) of that Act
                            shall, with the mutual consent of the Federated States of Micronesia or
                            the Republic of the Marshall Islands, as applicable, continue in the
                            manner authorized and required for fiscal year 2023 under the agreement
                            described in section 462(b)(1) of the Compact of Free Association
                            between the Government of the United States of America and the
                            Government of the Federated States of Micronesia set forth in section
                            201(a) of that Act and the agreement described in section 462(b)(1) of
                            the Compact of Free Association between the Government of the United
                            States of America and the Government of the Republic of the Marshall
                            Islands set forth in section 201(b) of that Act, respectively
                                    
                        137 STAT.
                                    82
                      . 
               
            
            <section display-inline="no-display-inline"
                     id="H2E62CF3D170B4CB8A94BAFEE66FFA76E"
                     qb-display-quote="yes"
                     section-type="subsequent-section">
               2102.
               EXTENSION OF DEADLINE TO PROMULGATE CERTAIN REGULATIONS
               Section 413(a) of the Indian
                        Self-Determination and Education Assistance Act (25 U.S.C. 5373(a)) is
                        amended—
               <paragraph display-inline="no-display-inline"
                          id="H2F2FA9AE8A934A88A39AC5B1F6434B52"
                          qb-display-quote="yes">
                  (1)
                  in paragraph (2), by striking <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">21 months and inserting
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">38 months; and
               
               <paragraph display-inline="no-display-inline"
                          id="H8ED70481E2EB4BAD94D43BE6D3A93583"
                          qb-display-quote="yes">
                  (2)
                  in paragraph (3), by striking <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">30 months and inserting
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">50 months.
               
            
         
         <title id="H5188649ABDF34EF1AA687ECB09FE9950"
                qb-display-quote="yes"
                style="OLC">
            II
            FAA EXTENSION
            <subtitle id="HFD7A729EBC3C439989710AA0399E1822"
                      qb-display-quote="yes"
                      style="OLC">
               A
               Federal Aviation Programs
               
                  Time periods.
               
               <section display-inline="no-display-inline"
                        id="HEDC636DBA9AE4812B43B988D4585DAB6"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2201.
                  AIRPORT IMPROVEMENT PROGRAM
                  <subsection display-inline="no-display-inline"
                              id="H4F09DFD6C68B410B9ACCF42E9E572855"
                              qb-display-quote="yes">
                     (a)
                     Authorization of appropriations
                     Section 48103(a) of title 49, United States Code, is
                                amended—
                     <paragraph display-inline="no-display-inline"
                                id="HCD2D0E030AC9405981B91BC3428034EF"
                                qb-display-quote="yes">
                        (1)
                        in paragraph (5) by striking the <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and at the
                                    end;
                     
                     <paragraph display-inline="no-display-inline"
                                id="HED3D1D87A2464E37BD0C92B2FFC4B745"
                                qb-display-quote="yes">
                        (2)
                        in paragraph (6) by striking the period at the end and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">; and; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H6B2A13C6D9654760BFEC95FA5073C139"
                                qb-display-quote="yes">
                        (3)
                        by adding at the end the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="HE7489E218D484B55B2250B91CED96CE4"
                                      style="OLC">
                           <paragraph display-inline="no-display-inline"
                                      id="H18E26ED659584F4A9BC31E8E06EEE344"
                                      qb-display-quote="yes">
                              (7)
                              $842,076,502 for the period beginning on October 1,
                                            2023, and ending on December 31, 2023.
                           
                           .
                        
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H77E0FA456EDB4397B14F7CD287FC176A"
                              qb-display-quote="yes">
                     (b)
                     Obligation authority
                     Subject to limitations specified in advance in appropriation Acts,
                                sums made available pursuant to the amendment made by subsection (a)
                                may be obligated at any time through September 30, 2024, and shall
                                remain available until expended.
                  
                  <subsection display-inline="no-display-inline"
                              id="HC1A553C87CF046ABAF43EBA583333422"
                              qb-display-quote="yes">
                     (c)
                     Program implementation
                     For purposes of calculating funding apportionments and meeting
                                other requirements under sections 47114, 47115, 47116, and 47117 of
                                title 49, United States Code, for the period beginning on October 1,
                                2023, and ending on December 31, 2023, the Administrator of the
                                Federal Aviation Administration shall—
                     <paragraph display-inline="no-display-inline"
                                id="H8C91A4DBB3CE4A19B03BE4A35975C915"
                                qb-display-quote="yes">
                        (1)
                        first calculate such funding apportionments on an annualized
                                    basis as if the total amount available under section 48103 of
                                    such title for fiscal year 2024 was $3,350,000,000; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="HDF456AD097F6422893A3473313ECECC3"
                                qb-display-quote="yes">
                        (2)
                        then reduce by 75 percent—
                        <subparagraph display-inline="no-display-inline"
                                      id="H37D0B5337E4D4F53ADC3945D492D61AB"
                                      qb-display-quote="yes">
                           (A)
                           all funding apportionment amounts calculated under
                                        paragraph (1); and
                        
                        <subparagraph display-inline="no-display-inline"
                                      id="H156FD3C3ECAB4237B3A8F30AD600D84B"
                                      qb-display-quote="yes">
                           (B)
                           amounts made available pursuant to subsections (b) and
                                        (f)(2) of section 47117 of such title.
                        
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H2B8060F451224C1FA6CC178C6908DC8A"
                              qb-display-quote="yes">
                     (d)
                     Extension of project grant authority
                     Section 47104(c) of title 49, United States Code, is amended in
                                the matter preceding paragraph (1) by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30,
                                    2023, and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31,
                                2023,.
                  
                  <subsection display-inline="no-display-inline"
                              id="HFD74601172734E35BBCDA9CB872B3BE5"
                              qb-display-quote="yes">
                     (e)
                     Extension of special rule for apportionments
                     Section 47114(c)(1)(J) of title 49, United States Code, is amended
                                by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">2023 to and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">2023, and
                                    for the period beginning on October 1, 2023, and ending on
                                    December 31, 2023, to.
                  
               
               <section display-inline="no-display-inline"
                        id="H381B4210A2564DA780D9D44A2ECEED18"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2202.
                  EXTENSION OF EXPIRING AUTHORITIES; MISCELLANEOUS
                            AUTHORIZATIONS
                  <subsection display-inline="no-display-inline"
                              id="HDDBB19AD126844F2934A34276EDE9819"
                              qb-display-quote="yes">
                     (a)
                     Authority to provide insurance
                     Section 44310(b) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                     
                        137 STAT. 83
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H9CE7759964B142838D8BA9C98400D744"
                              qb-display-quote="yes">
                     (b)
                     Unmanned aircraft test ranges
                     Section 44803(h) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HE10B498CC85348858B7AA69A19F8A036"
                              qb-display-quote="yes">
                     (c)
                     Special authority for certain unmanned aircraft systems
                     Section 44807(d) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HBD553B4DB98449C485673108DB301789"
                              qb-display-quote="yes">
                     (d)
                     Extension of airport safety and airspace hazard mitigation and
                                enforcement
                     Section 44810(h) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H11E8234C89974C0BA57394F7F1228B7F"
                              qb-display-quote="yes">
                     (e)
                     Competitive access reporting requirement
                     Section 47107(r)(3) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">January
                                    1, 2024.
                  
                  <subsection display-inline="no-display-inline"
                              id="H274B9F7A657F4D19A3A65D683B552918"
                              qb-display-quote="yes">
                     (f)
                     Marshall islands, micronesia, and palau
                     Section 47115(i) of title 49, United States Code, is amended by
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">, and for the period beginning on October 1, 2023,
                                    and ending on December 31, 2023 after <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">fiscal
                                    years 2018 through 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HF9B0D756F5974E528DAF0133B02B4F0B"
                              qb-display-quote="yes">
                     (g)
                     Supplemental discretionary funds
                     Section 47115(j)(4)(A) of title 49, United States Code, is amended
                                by inserting at the end the following:
                     <quoted-block display-end-quotes="yes"
                                   display-inline="no-display-inline"
                                   display-quotes="yes"
                                   id="H7428C915878A45579661CC1DA47F9293"
                                   style="OLC">
                        <clause display-inline="no-display-inline"
                                id="HB5C2938CFA6747C39D8BF01168E87554"
                                qb-display-quote="yes">
                           (vi)
                           $140,401,803 for the period beginning on October 1, 2023,
                                        and ending on December 31, 2023.
                        
                        .
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H854DE7AC5C1F40EC8DC60D2824516F23"
                              qb-display-quote="yes">
                     (h)
                     Compatible land use planning and projects by state and local
                                governments
                     Section 47141(f) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HE8992B984F3F4EA78B694ABEA41667D6"
                              qb-display-quote="yes">
                     (i)
                     Non-movement area surveillance pilot program
                     Section 47143(c) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">January
                                    1, 2024.
                  
                  <subsection display-inline="no-display-inline"
                              id="HACB2D6F11F4E432482D3E11778D6892A"
                              qb-display-quote="yes">
                     (j)
                     Weather reporting programs
                     Section 48105 of title 49, United States Code, is amended by
                                adding at the end the following:
                     <quoted-block display-end-quotes="yes"
                                   display-inline="no-display-inline"
                                   display-quotes="yes"
                                   id="H236B896CCDD14F0AB22804286FA05E33"
                                   style="OLC">
                        <paragraph display-inline="no-display-inline"
                                   id="H6A7CC7B2969047B4AA97F9BFB8C1D009"
                                   qb-display-quote="yes">
                           (5)
                           $9,803,278 for the period beginning on October 1, 2023,
                                        and ending on December 31, 2023.
                        
                        .
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="HB1F5D7CC5CA548F690B3C20E18AA47F0"
                              qb-display-quote="yes">
                     (k)
                     Learning period
                     Section 50905(c)(9) of title 51, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">January
                                    1, 2024.
                  
                  <subsection display-inline="no-display-inline"
                              id="HB219C790B7DA4AB098007DDC96A61EB2"
                              qb-display-quote="yes">
                     (l)
                     Midway island airport
                     Section 186(d) of the Vision 100—Century of Aviation
                                Reauthorization Act (Public Law
                                    108–176; 117 Stat. 2518) is amended by inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">and for the period beginning on October 1, 2023, and
                                    ending on December 31, 2023, after <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">fiscal years
                                    2018 through 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H47C573D014A74656A0C6C6473C3EFCDF"
                              qb-display-quote="yes">
                     (m)
                     Final order establishing mileage and adjustment
                                eligibility
                     Section 409(d) of the Vision 100—Century of Aviation
                                Reauthorization Act (49 U.S.C. 41731 note) is amended by striking
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December
                                    31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H30EC9807D1A443AAB8B43FFB5E596E81"
                              qb-display-quote="yes">
                     (n)
                     Contract weather observers
                     Section 2306(b) of the FAA Extension, Safety, and Security Act of
                                2016 (Public Law
                                    114–190; 130 Stat. 641) is amended by striking
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">January 1,
                                    2024.
                  
                  <subsection display-inline="no-display-inline"
                              id="HE386D4C477964C7E8E35CA36760F6734"
                              qb-display-quote="yes">
                     (o)
                     Remote tower pilot program
                     Section 161(a)(10) of the FAA Reauthorization Act of 2018
                                    (49 U.S.C.
                                    47104 note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September
                                    30, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31,
                                2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HD7AC51A61A7642D5803FE3F0E7276109"
                              qb-display-quote="yes">
                     (p)
                     Airport access roads in remote locations; storage facilities for
                                snow removal equipment
                     Section 162 of the FAA Reauthorization Act of 2018 (49 U.S.C 47102 note) is
                                amended by inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">and for the period beginning on October
                                    1, 2023, and ending on December 31, 2023 after
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">fiscal years 2018 through 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H3065615CA86840F591B729B613B968EE"
                              qb-display-quote="yes">
                     (q)
                     UAS remote detection and identification pilot program
                     Section 372(d) of the FAA Reauthorization Act of 2018 (49 U.S.C. 44810
                                note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H663BC26598F646149B693B64AA0424DC"
                              qb-display-quote="yes">
                     (r)
                     Advisory committee for aviation consumer protection
                     Section 411(h) of the FAA Modernization and Reform Act of 2012
                                    (49 U.S.C.
                                    42301 note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September
                                    30, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31,
                                2023.
                     
                        49 USC note prec. 42301.
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H259B8617CA4E4CD0A9C8CEAD3CF6B14C"
                              qb-display-quote="yes">
                     (s)
                     Aviation consumer advocate
                     Section 424(e) of the FAA Reauthorization Act of 2018 (49 U.S.C. 42302
                                note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H98D3C37D4CAA4BE7BA099102D8E41A1B"
                              qb-display-quote="yes">
                     (t)
                     Advisory committee on air travel needs of passengers with
                                disabilities
                     Section 439(g) of the FAA Reauthorization Act of 2018 (49 U.S.C. 41705
                                note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H82E1F63A095E43E1A6AD1B1805B16ACA"
                              qb-display-quote="yes">
                     (u)
                     Enhanced traffic services
                     Section 547(e) of the FAA Reauthorization Act of 2018 (49 U.S.C. 40103
                                note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H54B207C686464F52BB2ED5FEB2C5C0AC"
                              qb-display-quote="yes">
                     (v)
                     Pilot program for redevelopment of airport properties
                     Section 822(k) of the FAA Modernization and Reform Act of 2012
                                    (49 U.S.C.
                                    47141 note) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September
                                    30, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31,
                                2023.
                  
               
               <section display-inline="no-display-inline"
                        id="H982DB41DC78846F9B992892528B65DAD"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2203.
                  FEDERAL AVIATION ADMINISTRATION OPERATIONS
                  Section 106(k) of title 49, United
                            States Code, is amended—
                  <paragraph display-inline="no-display-inline"
                             id="HE387944157D840A587D0E853668AC748"
                             qb-display-quote="yes">
                     (1)
                     in paragraph (1)—
                     <subparagraph display-inline="no-display-inline"
                                   id="H2A51C6E0313E44F7A68F0FB0CD08CDA7"
                                   qb-display-quote="yes">
                        (A)
                        in subparagraph (E) by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and at the
                                    end;
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="HF5AAD5FE70EF45938CDD22725C8D2372"
                                   qb-display-quote="yes">
                        (B)
                        in subparagraph (F) by striking the period at the end and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">; and; and
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="H3D2294CF4F204B5190DB22D996C9CD6E"
                                   qb-display-quote="yes">
                        (C)
                        by inserting after subparagraph (F) the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="HE074EE4EC16041C2B6703C20F4DD18C7"
                                      style="OLC">
                           <subparagraph display-inline="no-display-inline"
                                         id="HFC9D407F261F45F0BAC990A2B7756A8B"
                                         qb-display-quote="yes">
                              (G)
                              $2,995,027,322 for the period beginning on October 1,
                                            2023, and ending on December 31, 2023.
                           
                           ; and
                        
                     
                  
                  <paragraph display-inline="no-display-inline"
                             id="HEB51CA15434B4CEDB79898AC80E272F8"
                             qb-display-quote="yes">
                     (2)
                     in paragraph (3) by inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">and for the period beginning
                                    on October 1, 2023, and ending on December 31, 2023
                                after <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">fiscal years 2018 through 2023.
                  
               
               <section display-inline="no-display-inline"
                        id="H4D0E608E71CB49D1A7B3A29BEF0FF75F"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2204.
                  AIR NAVIGATION FACILITIES AND EQUIPMENT
                  Section 48101(a) of title 49,
                            United States Code, is amended by adding at the end the
                            following:
                  <quoted-block display-end-quotes="yes"
                                display-inline="no-display-inline"
                                display-quotes="yes"
                                id="H3110E55A03354C68892DDCD0BB15B038"
                                style="OLC">
                     <paragraph display-inline="no-display-inline"
                                id="H0EA649FD8127417F97CCD09E3A17DFB9"
                                qb-display-quote="yes">
                        (7)
                        $740,273,224 for the period beginning on October 1, 2023, and
                                    ending on December 31, 2023.
                     
                     .
                  
               
               <section display-inline="no-display-inline"
                        id="H49D6A901A4C24672953204793145719A"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2205.
                  RESEARCH, ENGINEERING, AND DEVELOPMENT
                  Section 48102(a) of title 49,
                            United States Code, is amended—
                  <paragraph display-inline="no-display-inline"
                             id="HB6983410B1C649438F982D8BDAF87F75"
                             qb-display-quote="yes">
                     (1)
                     in paragraph (14), by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">and;
                  
                  <paragraph display-inline="no-display-inline"
                             id="HBC7D4A1E13B54B4B848931198043BA41"
                             qb-display-quote="yes">
                     (2)
                     in paragraph (15) by striking the period at the end and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">; and; and
                  
                  <paragraph display-inline="no-display-inline"
                             id="H41DAA1730A9D42BC9E1B399F4A01B957"
                             qb-display-quote="yes">
                     (3)
                     by adding at the end the following:
                     <quoted-block display-end-quotes="yes"
                                   display-inline="no-display-inline"
                                   display-quotes="yes"
                                   id="HAD37E1A0FF5547E3961E34688FFE5C58"
                                   style="OLC">
                        <paragraph display-inline="no-display-inline"
                                   id="H82283AB6FB16480DAE30A0B100368B92"
                                   qb-display-quote="yes">
                           (16)
                           $64,098,360 for the period beginning on October 1, 2023,
                                        and ending on December 31, 2023.
                           
                              137 STAT. 85
                           
                        
                        .
                     
                  
               
               <section display-inline="no-display-inline"
                        id="H744F7992F8D847B584ED6B9BA16FF354"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2206.
                  SMALL COMMUNITY AIR SERVICE
                  <subsection display-inline="no-display-inline"
                              id="HDCBFF000EFCA494D9DDBB882D03EE052"
                              qb-display-quote="yes">
                     (a)
                     Essential air service authorization
                     Section 41742(a)(2) of title 49, United States Code, is amended by
                                striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">2023, and
                                    $89,191,486 for the period beginning on October 1, 2023, and
                                    ending on December 31, 2023,.
                  
                  <subsection display-inline="no-display-inline"
                              id="H35F09E595BC44991B5FBF4BA6D50A5F4"
                              qb-display-quote="yes">
                     (b)
                     Airports not receiving sufficient service
                     Section 41743(e)(2) of title 49, United States Code, is amended by
                                inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">, and $2,513,661 for the period beginning on
                                    October 1, 2023, and ending on December 31, 2023, after
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">fiscal years 2018 through 2023.
                  
               
            
            <subtitle id="H489C56E650C54A9D94B8B4DD6BEC55C4"
                      qb-display-quote="yes"
                      style="OLC">
               B
               Aviation Revenue Provisions
               <section display-inline="no-display-inline"
                        id="H09B96A58438A44BDBB041134770A7EB5"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2211.
                  EXPENDITURE AUTHORITY FROM AIRPORT AND AIRWAY TRUST FUND
                  <subsection display-inline="no-display-inline"
                              id="HF54270EF40E14C41A8061AC7FF974366"
                              qb-display-quote="yes">
                     (a)
                     In general
                     
                        Section
                                    9502(d)(1) of the Internal Revenue Code of 1986 is
                                amended—
                     
                        26 USC
                                9502.
                     
                     
                        137 STAT.
                                81
                     
                     <paragraph display-inline="no-display-inline"
                                id="H7E57266A63B7449C9C0D26FBFA4B1484"
                                qb-display-quote="yes">
                        (1)
                        in the matter preceding subparagraph (A) by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">January
                                        1, 2024; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H2E3C8EAEBBDB42639D64571699589571"
                                qb-display-quote="yes">
                        (2)
                        in subparagraph (A) by striking the semicolon at the end and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">or title II of division B of the Continuing
                                        Appropriations Act, 2024 and Other Extensions
                                    Act;.
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="HEF95714C31A54B8A90D1D9E1D6AE914A"
                              qb-display-quote="yes">
                     (b)
                     Conforming amendment
                     Section 9502(e)(2) of such Code is amended by striking
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">January 1,
                                    2024.
                  
               
               <section display-inline="no-display-inline"
                        id="H953E979FFF1048FCA06D89755A5DE439"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2212.
                  EXTENSION OF TAXES FUNDING AIRPORT AND AIRWAY TRUST FUND
                  <subsection display-inline="no-display-inline"
                              id="H69AC0E4447A546DE9555FC2755108DF0"
                              qb-display-quote="yes">
                     (a)
                     Fuel taxes
                     
                        Section
                                    4081(d)(2)(B) of the Internal Revenue Code of 1986 is
                                amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30, 2023 and inserting
                                    <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">December 31, 2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HC97E8CBD774B4C5FB6CDC40D995DAE1A"
                              qb-display-quote="yes">
                     (b)
                     Ticket taxes
                     <paragraph display-inline="no-display-inline"
                                id="H679310D85D1A498DA7A2880514D20A1B"
                                qb-display-quote="yes">
                        (1)
                        Persons
                        Section 4261(k)(1)(A)(ii) of such Code is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">September 30, 2023 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">December 31, 2023.
                     
                     <paragraph display-inline="no-display-inline"
                                id="H7B11305EFE84415FB86CA8B5F2C747AF"
                                qb-display-quote="yes">
                        (2)
                        Property
                        Section 4271(d)(1)(A)(ii) of such Code is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">September 30, 2023 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">December 31, 2023.
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="HEE1061E64C4A4B6F8D2271D7A8EB1FCD"
                              qb-display-quote="yes">
                     (c)
                     Fractional ownership programs
                     <paragraph display-inline="no-display-inline"
                                id="H4FA7555B7B7046ABA303C0615553FDDD"
                                qb-display-quote="yes">
                        (1)
                        Fuel tax
                        Section 4043(d) of such Code is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">September 30, 2023 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">December 31, 2023.
                     
                     <paragraph display-inline="no-display-inline"
                                id="H36147A3EE23F4CC79D8BFE7754F2285B"
                                qb-display-quote="yes">
                        (2)
                        Treatment as noncommercial aviation
                        Section 4083(b) of such Code is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">October 1, 2023 and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">January
                                        1, 2024.
                     
                     <paragraph display-inline="no-display-inline"
                                id="H2CC6C28183544877AD9B80317D18E9CF"
                                qb-display-quote="yes">
                        (3)
                        Exemption from ticket tax
                        Section 4261(j) of such Code is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">September 30, 2023 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">December 31, 2023.
                        
                           137 STAT. 86
                        
                     
                  
               
            
            <subtitle id="H3EE9BBD261024718A88F2A39B9C90F33"
                      qb-display-quote="yes"
                      style="OLC">
               C
               Expiring Counter-UAS Authorities
               <section display-inline="no-display-inline"
                        id="HBF3AD16A61424093A37BAA63A3A2E2CF"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2221.
                  PROTECTION OF CERTAIN FACILITIES AND ASSETS FROM UNMANNED
                            AIRCRAFT
                  Section 210G(i) of the Homeland
                            Security Act of 2002 (6
                                U.S.C. 124n(i)) is amended by striking <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">on the date
                                that is 4 years after the date of enactment of this section
                            and inserting <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">on November 18, 2023.
               
            
         
         <title id="H1CE22EE4B6EC4290841D2C0D85366E08"
                qb-display-quote="yes"
                style="OLC">
            III
            HEALTH AND HUMAN SERVICES
            <subtitle id="HCF3D49374D654980AD7AC2B29036DA66"
                      qb-display-quote="yes"
                      style="OLC">
               A
               Animal Drug and Animal Generic Drug User Fee Amendments
               
                  1
                  Fees relating to animal drugs
                  <section display-inline="no-display-inline"
                           id="HD206005B132B40F2ADA29E4955C817A8"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2301.
                     SHORT TITLE; FINDING
                     <subsection display-inline="no-display-inline"
                                 id="HF9720F2B57C8489596A73CED214C09AB"
                                 qb-display-quote="yes">
                        (a)
                        Short title
                        
                           21 USC 301 note.
                        
                        This chapter may be cited as the <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">Animal Drug User Fee
                                        Amendments of 2023.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H12266347DD404895911407EEE8164567"
                                 qb-display-quote="yes">
                        (b)
                        Finding
                        
                           21 USC 379j-21 note.
                        
                        Congress finds that the fees authorized by the amendments made
                                    in this chapter will be dedicated toward expediting the animal
                                    drug development process and the review of new and supplemental
                                    animal drug applications and investigational animal drug
                                    submissions as set forth in the goals identified for purposes of
                                    part 4 of subchapter C of chapter VII of the Federal Food, Drug,
                                    and Cosmetic Act (21 U.S.C. 379j–11 et seq.), in the
                                    letters from the Secretary of Health and Human Services to the
                                    Chairman of the Committee on Energy and Commerce of the House of
                                    Representatives and the Chairman of the Committee on Health,
                                    Education, Labor, and Pensions of the Senate as set forth in the
                                    Congressional Record.
                     
                  
                  <section display-inline="no-display-inline"
                           id="H43ECB0C74B424C4AA9F107A5078F9155"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2302.
                     DEFINITIONS
                     Section 739 of the Federal
                                Food, Drug, and Cosmetic Act (21 U.S.C. 379j–11) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H6323344D16E2485B9776FB1EDC4779D5"
                                qb-display-quote="yes">
                        (1)
                        in paragraph (3), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">national drug
                                        code and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">National Drug
                                    Code; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H15B4B64C9C6C42558974691858290B26"
                                qb-display-quote="yes">
                        (2)
                        by amending paragraph (8)(I) to read as follows:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H8B8CFC3A93AD4CF497AA96E357FE99F5"
                                      style="OLC">
                           <subparagraph display-inline="no-display-inline"
                                         id="H3359912051FA4734BB128035B75001DF"
                                         qb-display-quote="yes">
                              (I)
                              The activities necessary for implementation of the
                                            United States and European Union Mutual Recognition
                                            Agreement for Pharmaceutical Good Manufacturing Practice
                                            Inspections, and the United States and United Kingdom
                                            Mutual Recognition Agreement Sectoral Annex for
                                            Pharmaceutical Good Manufacturing Practices, and other
                                            mutual recognition agreements, with respect to animal
                                            drug products subject to review, including
                                            implementation activities prior to and following product
                                            approval.
                              
                                 137 STAT.
                                                87
                              
                           
                           .
                        
                     
                  
                  <section display-inline="no-display-inline"
                           id="H4C826B60E03F44699820C703274E757E"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2303.
                     AUTHORITY TO ASSESS AND USE ANIMAL DRUG FEES
                     <subsection display-inline="no-display-inline"
                                 id="H7BBBDB23444B42A4ABA0EBD9D021077F"
                                 qb-display-quote="yes">
                        (a)
                        In general
                        Section 740(a)(1)(A)(ii) of the Federal Food, Drug, and
                                    Cosmetic Act (21 U.S.C. 379j– 12(a)(1)(A)(ii)) is
                                    amended—
                        <paragraph display-inline="no-display-inline"
                                   id="H316335CC2ECA4D31927CDCFAAC74A4C6"
                                   qb-display-quote="yes">
                           (1)
                           in subclause (I), by striking <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">and at the
                                        end;
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H7491A24589D348C0946290CD1326F59E"
                                   qb-display-quote="yes">
                           (2)
                           in subclause (II), by striking the period at the end and
                                        inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">; and; and
                        
                        <paragraph display-inline="no-display-inline"
                                   id="HF1A66BB54DA84061B6E9CF9FB9C0E84A"
                                   qb-display-quote="yes">
                           (3)
                           by adding at the end the following:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="H4C527F8568E64F1EB8EDDE6BDDF54CAA"
                                         style="OLC">
                              <subclause display-inline="no-display-inline"
                                         id="HCCA264F66DDD4BF680247B5D2307E43F"
                                         qb-display-quote="yes">
                                 (III)
                                 an application for conditional approval under
                                                section 571 of a new animal drug for which an animal
                                                drug application submitted under section 512(b)(1)
                                                has been previously approved under section 512(d)(1)
                                                for another intended use.
                              
                              .
                           
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H23813122A74E4763BD0C74F8CC682A15"
                                 qb-display-quote="yes">
                        (b)
                        Fee revenue amounts
                        Section 740(b)(1) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–12(b)(1)) is amended to read as
                                    follows:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H552A984FE0A647F5920B90E38AC3E728"
                                      style="OLC">
                           <paragraph display-inline="no-display-inline"
                                      id="HF13140D08D8F467FB2E750759E6358D7"
                                      qb-display-quote="yes">
                              (1)
                              In general
                              
                                 Time periods.
                              
                              Subject to subsections (c), (d), (f), and (g), for
                                            each of fiscal years 2024 through 2028, the fees
                                            required under subsection (a) shall be established to
                                            generate a total revenue amount of $33,500,000.
                           
                           .
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H777E1F4930674559BC15AC5C915F444B"
                                 qb-display-quote="yes">
                        (c)
                        Annual fee setting; adjustments
                        <paragraph display-inline="no-display-inline"
                                   id="H963D0AC839A343749D0D82D0E3175CDD"
                                   qb-display-quote="yes">
                           (1)
                           Annual fee setting
                           Section 740(c)(1) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–12(c)(1)) is amended to read as
                                        follows:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="HC313B67BE8E74922B81866F56078CDF7"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="HE0F31DB9CBAF49818D5D2796D2D44A10"
                                         qb-display-quote="yes">
                                 (1)
                                 Annual fee setting
                                 
                                    Deadline.
                                 
                                 Not later than 60 days before the start of each
                                                fiscal year beginning after September 30, 2023, the
                                                Secretary shall—
                                 <subparagraph display-inline="no-display-inline"
                                               id="H7DE568CD13B04D31BC981F718BF08DFF"
                                               qb-display-quote="yes">
                                    (A)
                                    establish for that fiscal year animal drug
                                                  application fees, supplemental animal drug
                                                  application fees, animal drug sponsor fees, animal
                                                  drug establishment fees, and animal drug product
                                                  fees based on the revenue amounts established
                                                  under subsection (b) and the adjustments provided
                                                  under this subsection; and
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="HE2D7E28810F04A95A0897C37B38AD627"
                                               qb-display-quote="yes">
                                    (B)
                                    publish such fee revenue amounts and fees in
                                                  the Federal Register.
                                    
                                       Federal Register,
                                                  publication.
                                    
                                 
                              
                              .
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H91DF98990038434F83E5F9F55DD262B2"
                                   qb-display-quote="yes">
                           (2)
                           Inflation adjustment
                           Section 740(c)(2) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–12(c)(2)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="HE4D2B30D533241859B63EEBA1C5BFD52"
                                         qb-display-quote="yes">
                              (A)
                              in subparagraph (A)—
                              <clause display-inline="no-display-inline"
                                      id="HE0FA354A371F400DA6ED884FC83F173F"
                                      qb-display-quote="yes">
                                 (i)
                                 in the matter preceding clause (i), by striking
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2020 and inserting
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2025; and
                              
                              <clause display-inline="no-display-inline"
                                      id="H007A6E5231D3498A9A614C462C15FF2A"
                                      qb-display-quote="yes">
                                 (ii)
                                 in clause (iii), by striking
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">Baltimore and inserting
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">Arlington-Alexandria; and
                              
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H60B4AEAD9A724AB5B4D647338A53A422"
                                         qb-display-quote="yes">
                              (B)
                              in subparagraph (B), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2020
                                            and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2025.
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="HAA522BBB9B6248AB81630FBCBF4591A6"
                                   qb-display-quote="yes">
                           (3)
                           Workload adjustments
                           Section 740(c)(3) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–12(c)(3)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="H5B44F7C5E58B4F6480795FEF3ACF3095"
                                         qb-display-quote="yes">
                              (A)
                              in subparagraph (A)—
                              <clause display-inline="no-display-inline"
                                      id="H677B293428804DFDA40AA7865D0ECB32"
                                      qb-display-quote="yes">
                                 (i)
                                 in the matter preceding clause (i)—
                                 <subclause display-inline="no-display-inline"
                                            id="H8C7081E9E8684996855161BDCD94563B"
                                            qb-display-quote="yes">
                                    (I)
                                    by striking <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">2020 and inserting
                                                  <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">2025; and
                                 
                                 <subclause display-inline="no-display-inline"
                                            id="H69FDFB83FB604119ACE3CBB9E8301856"
                                            qb-display-quote="yes">
                                    (II)
                                    by striking <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">subparagraphs (B) and
                                                  (C) and inserting <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">subparagraph
                                                  (B); 
                                 
                              
                              <clause display-inline="no-display-inline"
                                      id="H7C9D180C53524A83B5FD18C140468DDF"
                                      qb-display-quote="yes">
                                 (ii)
                                 in clause (i) by striking <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">and at
                                                the end; and
                              
                              <clause display-inline="no-display-inline"
                                      id="HCC5C9074F71D4C3F914699F1069EB85F"
                                      qb-display-quote="yes">
                                 (iii)
                                 by striking clause (ii) and inserting the
                                                following 
                                       137 STAT. 88
                                    
                                                :
                                 <quoted-block display-end-quotes="yes"
                                               display-inline="no-display-inline"
                                               display-quotes="yes"
                                               id="HF761CF254A19477AA1472D6EB29CB7BF"
                                               style="OLC">
                                    <clause display-inline="no-display-inline"
                                            id="HD5609760E202494FB320415913BB0872"
                                            qb-display-quote="yes">
                                       (ii)
                                       such adjustment shall be made for each
                                                  fiscal year that the adjustment determined by the
                                                  Secretary is greater than 3 percent, except for
                                                  the first fiscal year that the adjustment is
                                                  greater than 3 percent; and
                                       
                                          Determination.
                                       
                                    
                                    <clause display-inline="no-display-inline"
                                            id="H0DD59B9391FB4F7D9D5219CF33CE21AE"
                                            qb-display-quote="yes">
                                       (iii)
                                       the Secretary shall publish in the Federal
                                                  Register notice under paragraph (1) the amount of
                                                  such adjustment and the supporting
                                                  methodologies.
                                       
                                          Federal Register, publication.
                                                  Notice.
                                       
                                    
                                    ;
                                 
                              
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="HA23931E7D31E42B2A42C001FE1BCCB5A"
                                         qb-display-quote="yes">
                              (B)
                              by striking subparagraph (B); and
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H4B8C9DF4ACD448ABAC98644C1B20858A"
                                         qb-display-quote="yes">
                              (C)
                              by redesignating subparagraph (C) as subparagraph
                                            (B).
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H3DE50AE2DC8040A59F222A22B2CBCE85"
                                   qb-display-quote="yes">
                           (4)
                           Final year adjustment
                           Section 740(c)(4) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–12(c)(4)) is amended to read as
                                        follows:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="H6D1372F98D8447A9BCF34E848793C4BA"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="H113AA9569AE94D5D85848B958DB0EDBA"
                                         qb-display-quote="yes">
                                 (4)
                                 Operating reserve adjustment
                                 
                                    Time periods.
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="H2607179268AC4D2282769922E6B02604"
                                               qb-display-quote="yes">
                                    (A)
                                    In general
                                    For fiscal year 2025 and each subsequent
                                                  fiscal year, after the fee revenue amount
                                                  established under subsection (b) is adjusted in
                                                  accordance with paragraphs (2) and (3), the
                                                  Secretary shall—
                                    <clause display-inline="no-display-inline"
                                            id="H78ABCB3E41164C69B33EE0A6FCD441DB"
                                            qb-display-quote="yes">
                                       (i)
                                       increase the fee revenue amount for such
                                                  fiscal year, if necessary to provide an operating
                                                  reserve of not less than 12 weeks; or
                                    
                                    <clause display-inline="no-display-inline"
                                            id="HFE60B4F31C924FF8962051F278534515"
                                            qb-display-quote="yes">
                                       (ii)
                                       if the Secretary has an operating reserve in
                                                  excess of the number of weeks specified in
                                                  subparagraph (C) for that fiscal year, the
                                                  Secretary shall decrease the fee revenue amount to
                                                  provide not more than the number of weeks
                                                  specified in subparagraph (C) for that fiscal
                                                  year.
                                    
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="H28A0BAC134864F12A00C74C85B2F685F"
                                               qb-display-quote="yes">
                                    (B)
                                    Carryover user fees
                                    For purposes of this paragraph, the operating
                                                  reserve of carryover user fees for the process for
                                                  the review of animal drug applications does not
                                                  include carryover user fees that have not been
                                                  appropriated.
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="H007645C7775D48B193639C5FF0430FF4"
                                               qb-display-quote="yes">
                                    (C)
                                    Number of weeks of operating
                                                  reserves
                                    The number of weeks of operating reserves
                                                  specified in this subparagraph is—
                                    <clause display-inline="no-display-inline"
                                            id="H4358D494961C4A25BC5150FEFC976FD3"
                                            qb-display-quote="yes">
                                       (i)
                                       22 weeks for fiscal year 2025;
                                    
                                    <clause display-inline="no-display-inline"
                                            id="H4648AABB417546738B36EDC81F96ACF9"
                                            qb-display-quote="yes">
                                       (ii)
                                       20 weeks for fiscal year 2026;
                                    
                                    <clause display-inline="no-display-inline"
                                            id="HEAAFCE6B88114E518579115F1145295F"
                                            qb-display-quote="yes">
                                       (iii)
                                       18 weeks for fiscal year 2027; and
                                    
                                    <clause display-inline="no-display-inline"
                                            id="HD587B1105FBC4192A75E647F55539C5B"
                                            qb-display-quote="yes">
                                       (iv)
                                       16 weeks for fiscal year 2028.
                                    
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="HF6836C7228E4486288A86E40D3E45132"
                                               qb-display-quote="yes">
                                    (D)
                                    Publication
                                    
                                       Federal Register, publication.
                                                  Notice.
                                    
                                    If an adjustment to the operating reserve is
                                                  made under this paragraph, the Secretary shall
                                                  publish in the Federal Register notice under
                                                  paragraph (1) the rationale for the amount of the
                                                  adjustment and the supporting
                                                  methodologies.
                                 
                              
                              .
                           
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="HFE026A80694C434FA8A04710C3DFF5BB"
                                 qb-display-quote="yes">
                        (d)
                        Exemption from fees
                        Section 740(d)(4) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–12(d)(4)) is amended to read as
                                    follows:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H6F0D0C3FCE2A46B698E29CE537E19D93"
                                      style="OLC">
                           <paragraph display-inline="no-display-inline"
                                      id="H47776EA2289641CE9F851B12ADABF9DC"
                                      qb-display-quote="yes">
                              (4)
                              Exemption from fees
                              Fees under paragraphs (2), (3), and (4) of subsection
                                            (a) shall not apply with respect to any person who is
                                            the named applicant or sponsor of an animal drug
                                            application, supplemental animal drug application, or
                                            investigational animal drug submission if such
                                            application or submission involves the intentional
                                            genomic alteration of an animal that is intended to
                                            produce a drug, device, or biological product subject to
                                            fees under section 736, 738, 744B, or 744H.
                           
                           .
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H1A2390E4B7C54F25A6B46ECD6120BF01"
                                 qb-display-quote="yes">
                        (e)
                        Crediting and availability of fees
                        
                           137 STAT. 89
                        
                        <paragraph display-inline="no-display-inline"
                                   id="HE068034632A84C6DA2288B79E707F4AE"
                                   qb-display-quote="yes">
                           (1)
                           Authorization of appropriations
                           Section 740(g)(3) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–12(g)(3)) is amended by striking
                                            <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2019 through 2023 and inserting
                                            <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2024 through 2028.
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H9C150A5EF7D344F9AD0159B8EA13A838"
                                   qb-display-quote="yes">
                           (2)
                           Collection shortfalls
                           Section 740(g) of the Federal Food, Drug, and Cosmetic Act
                                            (21
                                            U.S.C. 379j–12(g)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="HE5181CF3FD2F4300AC0EFEF632DE3574"
                                         qb-display-quote="yes">
                              (A)
                              in paragraph (3), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">and paragraph
                                                (5); and
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H28817B753F8F4976851E62970AA54552"
                                         qb-display-quote="yes">
                              (B)
                              by striking paragraph (5).
                           
                        
                     
                  
                  <section display-inline="no-display-inline"
                           id="HC6BFF538583D4D0C8229E89D47B8F066"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2304.
                     REAUTHORIZATION; REPORTING REQUIREMENTS
                     Section 740A of the Federal
                                Food, Drug, and Cosmetic Act (21 U.S.C. 379j–13) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H5BEF39D4FF544294A4702E01C4391CD6"
                                qb-display-quote="yes">
                        (1)
                        in subsection (a), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2018 and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2023;
                     
                     <paragraph display-inline="no-display-inline"
                                id="H5FF3A7DF5B7640B39400BB92A42DD06E"
                                qb-display-quote="yes">
                        (2)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2019 each place it appears in
                                    subsections (a) and (b) and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2024;
                                    and
                     
                     <paragraph display-inline="no-display-inline"
                                id="HE1901C05FB2545D591B6694AC19BD6F4"
                                qb-display-quote="yes">
                        (3)
                        in subsection (d)—
                        <subparagraph display-inline="no-display-inline"
                                      id="HF43026ABBA614D969A81B5CB03186A76"
                                      qb-display-quote="yes">
                           (A)
                           in paragraph (1), by striking <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2023 and
                                        inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2028; and
                        
                        <subparagraph display-inline="no-display-inline"
                                      id="H7712A96898AD433C9885190C3A5B7B8D"
                                      qb-display-quote="yes">
                           (B)
                           in paragraph (5), by striking <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2023 and
                                        inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2028.
                        
                     
                  
                  <section display-inline="no-display-inline"
                           id="HA805197FAE70432D9A3DF6A6E6225286"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2305.
                     SAVINGS CLAUSE
                     
                        Extension. Time period. 21 USC 379j-11
                                    note.
                     
                     Notwithstanding the amendments
                                made by this chapter, part 4 of subchapter C of chapter VII of the
                                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–11 et
                                seq.), as in effect on the day before the date of
                                enactment of this chapter, shall continue to be in effect with
                                respect to animal drug applications and supplemental animal drug
                                applications (as defined in such part as of such day) that on or
                                after October 1, 2018, but before October 1, 2023, were accepted by
                                the Food and Drug Administration for filing with respect to
                                assessing and collecting any fee required by such part for a fiscal
                                year prior to fiscal year 2024.
                  
                  <section display-inline="no-display-inline"
                           id="HF84EF1A5AA454E708A39F2D19DA64663"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2306.
                     EFFECTIVE DATE
                     
                        Assessment. 21 USC 379j-11 note.
                     
                     The amendments made by this
                                chapter shall take effect on October 1, 2023, or the date of the
                                enactment of this Act, whichever is later, except that fees under
                                part 4 of subchapter C of chapter VII of the Federal Food, Drug, and
                                Cosmetic Act (21
                                    U.S.C. 379j–11 et seq.), as amended by this chapter,
                                shall be assessed for animal drug applications and supplemental
                                animal drug applications received on or after October 1, 2023,
                                regardless of the date of the enactment of this Act.
                  
                  <section display-inline="no-display-inline"
                           id="HE08BEC7698434D6EA9A2E13E770DEF27"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2307.
                     SUNSET DATES
                     <subsection display-inline="no-display-inline"
                                 id="H65BCAD7C009F4176A14352A62593F13E"
                                 qb-display-quote="yes">
                        (a)
                        Authorization
                        
                           21 USC 379j-11 note.
                        
                        Sections 739 and 740 of the Federal Food, Drug, and Cosmetic
                                    Act (21 U.S.C. 21 U.S.C. 379j–11; 379j–12) shall cease to be
                                    effective October 1, 2028.
                     
                     <subsection display-inline="no-display-inline"
                                 id="HC60ED4C025D5423AAD8AC72C2DE929B5"
                                 qb-display-quote="yes">
                        (b)
                        Reporting requirements
                        
                           21 USC 379j-13 note.
                        
                        
                           21 USC 379j-22 note.
                        
                        Section 740A of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–13) shall cease to be effective January 31,
                                    2029.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H5F4BFCC1548B4CC2B3BB3271D1D55041"
                                 qb-display-quote="yes">
                        (c)
                        Previous sunset provision
                        
                           Repeals. 21 USC 379j-12 note. 21 USC 379j-12 note,
                                        379j-13 note.
                        
                        Effective October 1, 2023, subsections (a) and (b) of section
                                    107 of the Animal Drug User Fee Amendments of 2018 (Public Law 115–234) are
                                    repealed.
                        
                           137 STAT. 90
                        
                     
                  
               
               
                  2
                  Fees relating to generic animal drugs
                  <section display-inline="no-display-inline"
                           id="H50990BF9CC1D4DB6A283EE3E53ACA749"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2311.
                     SHORT TITLE; FINDING
                     
                        Animal Generic Drug User Fee Amendments of
                                    2023.
                     
                     <subsection display-inline="no-display-inline"
                                 id="HEF823B2FC1944383B13308802AA169FF"
                                 qb-display-quote="yes">
                        (a)
                        Short title
                        
                           21 USC 301 note.
                        
                        This chapter may be cited as the <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">Animal Generic Drug
                                        User Fee Amendments of 2023.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H95005DE5A8DD437196E325C6F28EA873"
                                 qb-display-quote="yes">
                        (b)
                        Finding
                        
                           21 USC 379j-11 note.
                        
                        Congress finds that the fees authorized by the amendments made
                                    in this chapter will be dedicated toward expediting the generic
                                    new animal drug development process and the review of
                                    abbreviated applications for generic new animal drugs,
                                    supplemental abbreviated applications for generic new animal
                                    drugs, and investigational submissions for generic new animal
                                    drugs as set forth in the goals identified for purposes of part
                                    5 of subchapter C of chapter VII of the Federal Food, Drug, and
                                    Cosmetic Act (21
                                        U.S.C. 379j–21 et seq.), in the letters from the
                                    Secretary of Health and Human Services to the Chairman of the
                                    Committee on Energy and Commerce of the House of Representatives
                                    and the Chairman of the Committee on Health, Education, Labor,
                                    and Pensions of the Senate as set forth in the Congressional
                                    Record.
                     
                  
                  <section display-inline="no-display-inline"
                           id="H2F7916C91B5345DFA5A08665F387CDCF"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2312.
                     AUTHORITY TO ASSESS AND USE GENERIC NEW ANIMAL DRUG
                                FEES
                     <subsection display-inline="no-display-inline"
                                 id="H466D450E55AD421A9F07046CF3D54EF8"
                                 qb-display-quote="yes">
                        (a)
                        Generic investigational new animal drug file fee
                        Section 741(a) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–21(a)) is amended by adding at the end the
                                    following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H8E2AC907A28A41DD930447169A81CA81"
                                      style="OLC">
                           <paragraph display-inline="no-display-inline"
                                      id="HC7B5DFEB3286401AA6822CB0026A96FD"
                                      qb-display-quote="yes">
                              (4)
                              Generic investigational new animal drug file
                                            fee
                              <subparagraph display-inline="no-display-inline"
                                            id="HFAEDBD95094B40ECB557E7168D3A9CD3"
                                            qb-display-quote="yes">
                                 (A)
                                 In general
                                 
                                    Effective date.
                                 
                                 <clause display-inline="no-display-inline"
                                         id="H5D01223EB97E48898F307E414562B637"
                                         qb-display-quote="yes">
                                    (i)
                                    New file request
                                    Each person that submits a request to
                                                  establish a generic investigational new animal
                                                  drug file on or after October 1, 2023, shall be
                                                  assessed a fee as established under subsection
                                                  (c).
                                 
                                 <clause display-inline="no-display-inline"
                                         id="HD8EF41A89789489296CEA35F1079DBE9"
                                         qb-display-quote="yes">
                                    (ii)
                                    New submission to established file
                                    Each person that makes a submission to a
                                                  generic investigational new animal drug file on or
                                                  after October 1, 2023, where such file was
                                                  established prior to October 1, 2023, shall be
                                                  assessed a fee for the first submission on or
                                                  after October 1, 2023, as established under
                                                  subsection (c).
                                 
                              
                              <subparagraph display-inline="no-display-inline"
                                            id="HC65EA58C5AD643F9860FFD32A37B1212"
                                            qb-display-quote="yes">
                                 (B)
                                 Payment
                                 <clause display-inline="no-display-inline"
                                         id="H45E5EEAF08284C50832DF3F018B4A79E"
                                         qb-display-quote="yes">
                                    (i)
                                    New file request
                                    The fee required by subparagraph (A)(i) shall
                                                  be due upon submission of the request to establish
                                                  the generic investigational new animal drug
                                                  file.
                                 
                                 <clause display-inline="no-display-inline"
                                         id="H36F4BEDC2FB9492189944CFDEA6478C4"
                                         qb-display-quote="yes">
                                    (ii)
                                    New submission to established file
                                    The fee required by subparagraph (A)(ii) shall
                                                  be due upon the first submission to the generic
                                                  investigational new animal drug file.
                                 
                              
                              <subparagraph display-inline="no-display-inline"
                                            id="H08788C41345F46DF94685C42C9ABC5E6"
                                            qb-display-quote="yes">
                                 (C)
                                 Exceptions
                                 <clause display-inline="no-display-inline"
                                         id="H31813AF5EC354712ACB8AE5AD050A091"
                                         qb-display-quote="yes">
                                    (i)
                                    Terminating an existing generic
                                                  investigational new animal drug file
                                    If a person makes a submission to the generic
                                                  investigational new animal drug file to terminate
                                                  that file, the person shall not be subject to a
                                                  fee under subparagraph (A)(ii) for that
                                                  submission.
                                 
                                 <clause display-inline="no-display-inline"
                                         id="H01CFE15006EE4044B8153C0CB41AAD83"
                                         qb-display-quote="yes">
                                    (ii)
                                    Transferring an existing generic
                                                  investigational new animal drug file
                                    If a person makes 
                                          137 STAT.
                                                  91
                                        a submission to the
                                                  generic investigational new animal drug file to
                                                  transfer that file to a different generic new
                                                  animal drug sponsor, the person shall not be
                                                  subject to a fee under subparagraph (A)(ii) for
                                                  that submission.
                                 
                              
                           
                           .
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H5BE0AECB97B34F7EBBD06FF3637EDF53"
                                 qb-display-quote="yes">
                        (b)
                        Fee revenue amounts
                        Section 741(b) of the Federal Food, Drug, and Cosmetic Act (21
                                    U.S.C. 379j– 21(b)) is amended—
                        <paragraph display-inline="no-display-inline"
                                   id="H9C9C84C95A214343976E057258C70F6B"
                                   qb-display-quote="yes">
                           (1)
                           in paragraph (1)—
                           <subparagraph display-inline="no-display-inline"
                                         id="H45C2BD857AD3473FB227B8E0FE3FAEF4"
                                         qb-display-quote="yes">
                              (A)
                              by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2019 through 2023 and
                                            inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2024 through 2028; and
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="HB9A8CE136401424CBA2DB5626C8F10C4"
                                         qb-display-quote="yes">
                              (B)
                              by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">$18,336,340 and inserting
                                                <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">$25,000,000; and
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H4B4E3ACF5D3246F3B1891C758433A9A4"
                                   qb-display-quote="yes">
                           (2)
                           in paragraph (2)—
                           <subparagraph display-inline="no-display-inline"
                                         id="HF6FDBF7750AF48359B85E1C0D3B5529C"
                                         qb-display-quote="yes">
                              (A)
                              in subparagraph (A)—
                              <clause display-inline="no-display-inline"
                                      id="HB0970DF6611F4B928FD06B59476B2A80"
                                      qb-display-quote="yes">
                                 (i)
                                 by striking <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">25 percent and
                                                inserting <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">20 percent; and
                              
                              <clause display-inline="no-display-inline"
                                      id="HFD250267D1A14445974297BF6E399C32"
                                      qb-display-quote="yes">
                                 (ii)
                                 by inserting before the semicolon at the end the
                                                following: <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">and fees under subsection (a)(4)
                                                  (relating to generic investigational new animal
                                                  drug files);
                              
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H63E8598F3475441F83CBD938F850F29F"
                                         qb-display-quote="yes">
                              (B)
                              in subparagraph (B), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">37.5
                                                percent and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">40
                                                percent; and
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H998660B518B8481C81F08D8CF9BC1FFF"
                                         qb-display-quote="yes">
                              (C)
                              in subparagraph (C), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">37.5
                                                percent and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">40
                                                percent.
                           
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="HFDED908B8AB94480A5622C2689169384"
                                 qb-display-quote="yes">
                        (c)
                        Annual fee setting; adjustments
                        <paragraph display-inline="no-display-inline"
                                   id="H4D29491BB05147989889B336E35FE328"
                                   qb-display-quote="yes">
                           (1)
                           Annual fee setting
                           Section 741(c)(1) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–21(c)(1)) is amended to read as
                                        follows:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="H74F4B49832D049BCA6C30F6DAA187C65"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="H1125BFAFE65242C2B0434F42CB5FC67A"
                                         qb-display-quote="yes">
                                 (1)
                                 Annual fee setting
                                 
                                    Deadlines.
                                 
                                 The Secretary shall establish, not later than 60
                                                days before the start of each fiscal year beginning
                                                after September 30, 2023, for that fiscal
                                                year—
                                 <subparagraph display-inline="no-display-inline"
                                               id="HFEBE24C51FE94943B6CBFB6C96E5DBDB"
                                               qb-display-quote="yes">
                                    (A)
                                    abbreviated application fees that are based on
                                                  the revenue amounts established under subsection
                                                  (b), the adjustments provided under this
                                                  subsection, and the amount of fees anticipated to
                                                  be collected under subsection (a)(4) during that
                                                  fiscal year;
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="HDB75AB533128437A851CA63D8F907CF9"
                                               qb-display-quote="yes">
                                    (B)
                                    generic new animal drug sponsor fees, and
                                                  generic new animal drug product fees, based on the
                                                  revenue amounts established under subsection (b)
                                                  and the adjustments provided under this
                                                  subsection; and
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="H43297996EE754831856F5ED598BD6759"
                                               qb-display-quote="yes">
                                    (C)
                                    a generic investigational new animal drug file
                                                  fee of $50,000 for each request or submission
                                                  described in subsection (a)(4)(A).
                                 
                              
                              .
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H93384251EC644BCB8F13EDB2689433B8"
                                   qb-display-quote="yes">
                           (2)
                           Inflation adjustment
                           Section 741(c)(2) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–21(c)(2)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="H2A44E715EA4C4404B149F7822B5E4A17"
                                         qb-display-quote="yes">
                              (A)
                              in subparagraph (A)—
                              
                                 137 STAT.
                                                92
                              
                              <clause display-inline="no-display-inline"
                                      id="HFC58317D2F1D4814B4E849C7E52272B8"
                                      qb-display-quote="yes">
                                 (i)
                                 in the matter preceding clause (i), by striking
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2020 and inserting
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2025; and
                              
                              <clause display-inline="no-display-inline"
                                      id="HFB5D4C9E9E6D4837972E78195F67B6E7"
                                      qb-display-quote="yes">
                                 (ii)
                                 in clause (iii), by striking
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">Baltimore and inserting
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">Arlington-Alexandria; and
                              
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="HD25DEC4A614C4929B47BDDBE2AD140D3"
                                         qb-display-quote="yes">
                              (B)
                              in subparagraph (B), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2020
                                            and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2025.
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H08092E46CA714A7F9B74A843AB8A71A9"
                                   qb-display-quote="yes">
                           (3)
                           Workload adjustment
                           Section 741(c)(3) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–21(c)(3)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="H958CF18EE571478EA84B465CD3358FED"
                                         qb-display-quote="yes">
                              (A)
                              in subparagraph (A)—
                              <clause display-inline="no-display-inline"
                                      id="H6B002F52062C47AD9550B0F7CD5CD24C"
                                      qb-display-quote="yes">
                                 (i)
                                 in the matter preceding clause (i), by striking
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2020 and inserting
                                                  <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">2025;
                              
                              <clause display-inline="no-display-inline"
                                      id="H250EB4EC10434D2E9EEB57351195E384"
                                      qb-display-quote="yes">
                                 (ii)
                                 in clause (i)—
                                 <subclause display-inline="no-display-inline"
                                            id="H52A7FA43A1A04C40981C4CFD48F6D5F1"
                                            qb-display-quote="yes">
                                    (I)
                                    by striking <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">and investigational generic
                                                  new animal drug protocol submissions and
                                                  inserting <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">investigational generic new
                                                  animal drug protocol submissions, requests to
                                                  establish a generic investigational new animal
                                                  drug file, and generic investigational new animal
                                                  drug meeting requests; and
                                 
                                 <subclause display-inline="no-display-inline"
                                            id="H008C47A578B649B5BFF68DD8FAD3C815"
                                            qb-display-quote="yes">
                                    (II)
                                    by striking <quote quote-display-end="auto"
                                              quote-display-start="auto"
                                              quote-type="text">; and and inserting
                                                  a semicolon;
                                 
                              
                              <clause display-inline="no-display-inline"
                                      id="H9379E98C24CB4B5290564E436CF0CA5B"
                                      qb-display-quote="yes">
                                 (iii)
                                 by redesignating clause (ii) as clause (iii);
                                                and
                              
                              <clause display-inline="no-display-inline"
                                      id="HC66DB7881AF64BAB9BD84CA2EEA5BE58"
                                      qb-display-quote="yes">
                                 (iv)
                                 by inserting after clause (i) the
                                                following:
                                 <quoted-block display-end-quotes="yes"
                                               display-inline="no-display-inline"
                                               display-quotes="yes"
                                               id="HA04B69456CA64A6883719B2C2645C8C6"
                                               style="OLC">
                                    <clause display-inline="no-display-inline"
                                            id="H86B36D31A8C3466C8939959A17D4FDF7"
                                            qb-display-quote="yes">
                                       (ii)
                                       if the workload adjustment calculated by the
                                                  Secretary under clause (i) exceeds 25 percent, the
                                                  Secretary shall use 25 percent for the adjustment;
                                                  and
                                    
                                    ; and
                                 
                              
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="HE42C44DAA67A41D0B5DEE2250C270495"
                                         qb-display-quote="yes">
                              (B)
                              in subparagraph (B), by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2021 through
                                                2023 and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2026 through
                                                2028.
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H91E249A5628E438ABFCDA28483D28119"
                                   qb-display-quote="yes">
                           (4)
                           Final year adjustment
                           Section 741(c)(4) of the Federal Food, Drug, and Cosmetic
                                        Act (21
                                            U.S.C. 379j–21(c)(4)) is amended—
                           <subparagraph display-inline="no-display-inline"
                                         id="H1889D94CEEF642268C46D4AAA90BDBD4"
                                         qb-display-quote="yes">
                              (A)
                              by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2023 each place it appears
                                            and inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2028; and
                           
                           <subparagraph display-inline="no-display-inline"
                                         id="H19767C41D2D44A93B45C1CA20AFE826E"
                                         qb-display-quote="yes">
                              (B)
                              by striking <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2024 and inserting
                                                <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2029.
                           
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H29728AD663B6451F87425CCBB3EECCA5"
                                 qb-display-quote="yes">
                        (d)
                        Fee waiver or reduction; exemption from fees
                        Subsection (d) of section 741 of the Federal Food, Drug, and
                                    Cosmetic Act (21
                                        U.S.C. 379j–21) is amended to read as
                                    follows:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H265934648D6A4F8E9683964207C2EA6F"
                                      style="OLC">
                           <subsection display-inline="no-display-inline"
                                       id="HB38332E558004FDCB111028D19A36986"
                                       qb-display-quote="yes">
                              (d)
                              Fee waiver or reduction
                              The Secretary shall grant a waiver from, or a
                                            reduction of, one or more fees assessed under subsection
                                            (a) where the Secretary finds that the generic new
                                            animal drug is intended solely to provide for a minor
                                            use or minor species indication.
                           
                           .
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H628467A57E39418C822B01C9834048EC"
                                 qb-display-quote="yes">
                        (e)
                        Effect of failure to pay fees
                        Section 741(e) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–21(e)) is amended by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">The
                                        Secretary may discontinue and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">A
                                        request to establish a generic investigational new animal
                                        drug file that is submitted by a person subject to fees
                                        under subsection (a) shall be considered incomplete and
                                        shall not be accepted for action by the Secretary until all
                                        fees owed by such person have been paid. The Secretary may
                                        discontinue.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H2ABD2535ADB94F45A42CDEA417FF4380"
                                 qb-display-quote="yes">
                        (f)
                        Assessment of fees
                        Section 741(f)(2) of the Federal Food, Drug, and Cosmetic Act
                                    (21 U.S.C. 379j– 21(f)(2)) is amended by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">sponsors, and generic new animal drug products at any
                                        time and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">products, generic new
                                        animal drug sponsors, and generic investigational new animal
                                        drug files at any time.
                     
                     <subsection display-inline="no-display-inline"
                                 id="HC5B9872439CF48909473CF8FCF80874F"
                                 qb-display-quote="yes">
                        (g)
                        Crediting and availability of fees
                        Section 741(g) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–21(g)) is amended—
                        <paragraph display-inline="no-display-inline"
                                   id="HFBC561C164FB4E9DA6A61BA496EE2599"
                                   qb-display-quote="yes">
                           (1)
                           in paragraph (3), by striking <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2019 through
                                            2023 and inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2024 through
                                            2028;
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H3632696383074F4C92FA6FBC1049F88D"
                                   qb-display-quote="yes">
                           (2)
                           by striking the second paragraph (4) (relating to Offset),
                                        as added by section 202 of the Animal Generic Drug User Fee
                                        Amendments of 2013 (Public Law 113–14); and
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H40094352F5854BC18DEEEF8B82FF03A9"
                                   qb-display-quote="yes">
                           (3)
                           by adding at the end the following 
                                 137 STAT.
                                            93
                               :
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="HF4285E6005F64276AA2BE86A0DA91BCC"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="HBD56A1548D4A4654A199D06EC5CC14BD"
                                         qb-display-quote="yes">
                                 (5)
                                 Recovery of collection shortfalls
                                 
                                    Time periods.
                                 
                                 The amount of fees otherwise authorized to be
                                                collected under this section shall be
                                                increased—
                                 <subparagraph display-inline="no-display-inline"
                                               id="HF7618598F680448F9BA1E825672A62BD"
                                               qb-display-quote="yes">
                                    (A)
                                    for fiscal year 2026, by the amount, if any,
                                                  by which the amount collected under this section
                                                  and appropriated for fiscal year 2024 falls below
                                                  the amount of fees authorized for fiscal year 2024
                                                  under paragraph (3);
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="HFA3B2913EC40404985BC1E875FC446A8"
                                               qb-display-quote="yes">
                                    (B)
                                    for fiscal year 2027, by the amount, if any,
                                                  by which the amount collected under this section
                                                  and appropriated for fiscal year 2025 falls below
                                                  the amount of fees authorized for fiscal year 2025
                                                  under paragraph (3); and
                                 
                                 <subparagraph display-inline="no-display-inline"
                                               id="H8F0215398A9E4D019F92B8C53F3D70D5"
                                               qb-display-quote="yes">
                                    (C)
                                    for fiscal year 2028, by the amount, if any,
                                                  by which the amount collected under this section
                                                  and appropriated for fiscal years 2026 and 2027
                                                  (including estimated collections for fiscal year
                                                  2027) falls below the amount of fees authorized
                                                  for such fiscal years under paragraph (3).
                                 
                              
                              .
                           
                        
                     
                     <subsection display-inline="no-display-inline"
                                 id="H41113EA0B60F4FEFA760CD0A4BDFDC83"
                                 qb-display-quote="yes">
                        (h)
                        Definitions
                        Section 741(k) of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–21(k)) is amended—
                        <paragraph display-inline="no-display-inline"
                                   id="HA1897EA711C14F9A965C5A0E66ED8398"
                                   qb-display-quote="yes">
                           (1)
                           by redesignating paragraphs (8), (9), (10), and (11) as
                                        paragraphs (9), (10), (11), and (13), respectively;
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H7DE324DE2CEA478487546EC9D2796171"
                                   qb-display-quote="yes">
                           (2)
                           by inserting after paragraph (7) the following:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="HE33BF31F0E0D4941B9C141C3DB2BFBF2"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="H4DF4FA1419FA47C4A338869F4F4EA0C9"
                                         qb-display-quote="yes">
                                 (8)
                                 Generic investigational new animal drug meeting
                                                request
                                 The term <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">generic investigational new animal
                                                  drug meeting request means a request
                                                submitted by a generic new animal drug sponsor to
                                                meet with the Secretary to discuss an
                                                investigational submission for a generic new animal
                                                drug.
                              
                              ;
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H1D365CB239584BF981D29E6B7206C39B"
                                   qb-display-quote="yes">
                           (3)
                           in paragraph (11) (as so redesignated), by adding at the
                                        end the following:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="HA4B8DB44C23A419C883CC87E801CE7F6"
                                         style="OLC">
                              <subparagraph display-inline="no-display-inline"
                                            id="H9EC061EC92BD4F92A4D9FF8FBD1B9F2A"
                                            qb-display-quote="yes">
                                 (I)
                                 The activities necessary for exploration and
                                                implementation of the United States and European
                                                Union Mutual Recognition Agreement for
                                                Pharmaceutical Good Manufacturing Practice
                                                Inspections, and the United States and United
                                                Kingdom Mutual Recognition Agreement Sectoral Annex
                                                for Pharmaceutical Good Manufacturing Practices, and
                                                other mutual recognition agreements, with respect to
                                                generic new animal drug products subject to review,
                                                including implementation activities prior to and
                                                following product approval.
                              
                              ; and
                           
                        
                        <paragraph display-inline="no-display-inline"
                                   id="H1DC4B3025B614A67BAFE0264B7C4BBDF"
                                   qb-display-quote="yes">
                           (4)
                           by inserting after paragraph (11) (as so redesignated) the
                                        following:
                           <quoted-block display-end-quotes="yes"
                                         display-inline="no-display-inline"
                                         display-quotes="yes"
                                         id="H7C10B42A82C74426B9D9407E38BE2625"
                                         style="OLC">
                              <paragraph display-inline="no-display-inline"
                                         id="H939DB75EE1F34843A77B7F79B00D52EA"
                                         qb-display-quote="yes">
                                 (12)
                                 Request to establish a generic investigational
                                                new animal drug file
                                 The term <quote quote-display-end="auto"
                                           quote-display-start="auto"
                                           quote-type="text">request to establish a generic
                                                  investigational new animal drug file means
                                                the submission to the Secretary of a request to
                                                establish a generic investigational new animal drug
                                                file to contain investigational submissions for a
                                                generic new animal drug.
                              
                              .
                           
                        
                     
                  
                  <section display-inline="no-display-inline"
                           id="H2910515C6E3D4D489859EE72B18BB0ED"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2313.
                     REAUTHORIZATION; REPORTING REQUIREMENTS
                     Section 742 of the Federal
                                Food, Drug, and Cosmetic Act (21 U.S.C. 379j–22) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H81EC68D846BE43EA97FEA47D3A432BE6"
                                qb-display-quote="yes">
                        (1)
                        in subsection (a), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2018 and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2023;
                     
                     <paragraph display-inline="no-display-inline"
                                id="HE6AEE6CB411A4E8B86C80C029269230B"
                                qb-display-quote="yes">
                        (2)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2019 each place it appears in
                                    subsections (a) and (b) and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2024;
                                    and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H4D0CFE8EB23A48C9B431B0647C003CBB"
                                qb-display-quote="yes">
                        (3)
                        in subsection (d), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2023 each place
                                    it appears and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2028.
                        
                           137 STAT. 94
                        
                     
                  
                  <section display-inline="no-display-inline"
                           id="H8BEF63DEE4BD4EA8BABA8A4A00BA3362"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2314.
                     SAVINGS CLAUSE
                     
                        Extension. Time period. 21 USC 379j-21
                                    note.
                     
                     Notwithstanding the amendments
                                made by this chapter, part 5 of subchapter C of chapter VII of the
                                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–21 et
                                seq.), as in effect on the day before the date of
                                enactment of this chapter, shall continue to be in effect with
                                respect to abbreviated applications for a generic new animal drug
                                and supplemental abbreviated applications for a generic new animal
                                drug (as defined in such part as of such day) that on or after
                                October 1, 2018, but before October 1, 2023, were accepted by the
                                Food and Drug Administration for filing with respect to assessing
                                and collecting any fee required by such part for a fiscal year prior
                                to fiscal year 2024.
                  
                  <section display-inline="no-display-inline"
                           id="H6A8573F2440D4486B5FFED2766258AAD"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2315.
                     EFFECTIVE DATE
                     
                        Assessment. 21 USC 379j-21 note.
                     
                     The amendments made by this
                                chapter shall take effect on October 1, 2023, or the date of the
                                enactment of this Act, whichever is later, except that fees under
                                part 5 of subchapter C of chapter VII of the Federal Food, Drug, and
                                Cosmetic Act (21
                                    U.S.C. 379j–21 et seq.), as amended by this chapter,
                                shall be assessed for abbreviated applications for a generic new
                                animal drug and supplemental abbreviated applications for a generic
                                new animal drug received on or after October 1, 2023, regardless of
                                the date of enactment of this Act.
                  
                  <section display-inline="no-display-inline"
                           id="H9264F30690DD4847A0E9D41C7417A07E"
                           qb-display-quote="yes"
                           section-type="subsequent-section">
                     2316.
                     SUNSET DATES
                     <subsection display-inline="no-display-inline"
                                 id="H785A2044D2864952833939346FFEDF05"
                                 qb-display-quote="yes">
                        (a)
                        Authorization
                        
                           21 USC 379j-21 note.
                        
                        Section 741 of the Federal Food, Drug, and Cosmetic Act
                                        (21 U.S.C.
                                        379j–21) shall cease to be effective October 1,
                                    2028.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H8DC36EA1CEC744E7AA84E733357EFA25"
                                 qb-display-quote="yes">
                        (b)
                        Reporting requirements
                        Section 742 of the Federal Food, Drug, and Cosmetic Act (21
                                    U.S.C. 379j– 22) shall cease to be effective January 31,
                                    2029.
                     
                     <subsection display-inline="no-display-inline"
                                 id="H6A46FAAE6B604AAABD6D7788BAA12725"
                                 qb-display-quote="yes">
                        (c)
                        Previous sunset provision
                        
                           Repeals. 21 USC 379j-21 note. 21 USC 379j-21 note,
                                        379j-22 note.
                        
                        Effective October 1, 2023, subsections (a) and (b) of section
                                    206 of the Animal Generic Drug User Fee Amendments of 2018
                                        (Public Law
                                        115–234) are repealed.
                     
                  
               
            
            <subtitle id="HBC22E0D5ABC5442AA1C19EC0445D26EA"
                      qb-display-quote="yes"
                      style="OLC">
               B
               Public Health Extenders
               <section display-inline="no-display-inline"
                        id="H4A05BEB4D3214B3487609484F817C7EE"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2321.
                  EXTENSION FOR COMMUNITY HEALTH CENTERS, NATIONAL HEALTH SERVICE
                            CORPS, AND TEACHING HEALTH CENTERS THAT OPERATE GME PROGRAMS
                  
                     Time periods.
                  
                  <subsection display-inline="no-display-inline"
                              id="HF1E9CD4F176E4C0FB26997AEB9B8496F"
                              qb-display-quote="yes">
                     (a)
                     Teaching health centers that operate graduate medical education
                                programs
                     Section 340H(g) of the Public Health Service Act (42 U.S.C. 256h(g))
                                is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H7F9C7AB573EA4854AC77237D26034888"
                                qb-display-quote="yes">
                        (1)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and $126,500,000 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">$126,500,000; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="HFC4E6301EB1149B29A4F2AB5A8771E25"
                                qb-display-quote="yes">
                        (2)
                        by inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and $16,635,616 for the period beginning
                                        on October 1, 2023, and ending on November 17, 2023,
                                    before <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">to remain available.
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="HB2522BDCF4874BAEBFDC964BDBCFA601"
                              qb-display-quote="yes">
                     (b)
                     Extension for community health centers
                     Section 10503(b)(1)(F) of the Patient Protection and Affordable
                                Care Act (42 U.S.C.
                                    254b–2(b)(1)(F)) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="HD25E92D0B7EA4FB19CD3A630957F7441"
                                qb-display-quote="yes">
                        (1)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and $4,000,000,000 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">, $4,000,000,000; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="HEB51ECE6649041848CF76507262D2527"
                                qb-display-quote="yes">
                        (2)
                        by inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">, and $526,027,397 for the period
                                        beginning on October 1, 2023, and ending on November 17,
                                        2023 before the semicolon.
                        
                           137 STAT. 95
                        
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H3D30059346CC462CA44CAF87F4C4E235"
                              qb-display-quote="yes">
                     (c)
                     Extension for the national health service corps
                     Section 10503(b)(2) of the Patient Protection and Affordable Care
                                Act (42 U.S.C.
                                    254b–2(b)(2)) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H678DE9CD1115446687F727CD2E4BA2D5"
                                qb-display-quote="yes">
                        (1)
                        in subparagraph (G), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and at the
                                    end;
                     
                     <paragraph display-inline="no-display-inline"
                                id="H90A54221FF784442966C68C2B48A969A"
                                qb-display-quote="yes">
                        (2)
                        in subparagraph (H), by striking the period at the end and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">; and; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H14B74D58B918425B96B824F71654155F"
                                qb-display-quote="yes">
                        (3)
                        by adding at the end the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H0CF3ABED6CB045F5A95630598FEC7106"
                                      style="OLC">
                           <subparagraph display-inline="no-display-inline"
                                         id="H4CC6FA264ECA432F9E189B80996007EE"
                                         qb-display-quote="yes">
                              (I)
                              $40,767,123 for the period beginning on October 1,
                                            2023, and ending on November 17, 2023.
                           
                           .
                        
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="HC6FB605D2CD3454F888485B3347B26C9"
                              qb-display-quote="yes">
                     (d)
                     Application of provisions
                     Amounts appropriated pursuant to the amendments made by this
                                section shall be subject to the requirements contained in Public Law 117–328 for
                                funds for programs authorized under sections 330 through 340 of the
                                Public Health Service Act (42 U.S.C. 254b et seq.).
                  
                  <subsection display-inline="no-display-inline"
                              id="H44D82A0C15CB45FA9EB3371455AC1C84"
                              qb-display-quote="yes">
                     (e)
                     Technical and conforming amendment
                     Section 3014(h)(4) of title 18, United States Code, is
                                amended—
                     <paragraph display-inline="no-display-inline"
                                id="HFB859066C1C54116BEBFBD144A228E78"
                                qb-display-quote="yes">
                        (1)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">Other Extensions Act,, and
                                    inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">Other Extensions Act,; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="HBC45CD31BB6E4CF88ECF88D038F575B2"
                                qb-display-quote="yes">
                        (2)
                        by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and section 301(d) of division BB of the
                                        Consolidated Appropriations Act, 2021. and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">section 301(d) of division BB of the Consolidated
                                        Appropriations Act, 2021, and section 2321(d) of the
                                        Continuing Appropriations Act, 2024 and Other Extensions
                                        Act.
                     
                  
               
               <section display-inline="no-display-inline"
                        id="H3F9FB9950D144A388D030571921B7B3B"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2322.
                  EXTENSION OF SPECIAL DIABETES PROGRAMS
                  <subsection display-inline="no-display-inline"
                              id="H398670AAD75747849F341D7E008E9117"
                              qb-display-quote="yes">
                     (a)
                     Extension of special diabetes programs for type I
                                diabetes
                     Section 330B(b)(2) of the Public Health Service Act (42 U.S.C.
                                    254c–2(b)(2)) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="H8351CC3CB7F94B8D9EB3B3BA573A7AF1"
                                qb-display-quote="yes">
                        (1)
                        in subparagraph (C), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and at the
                                    end;
                     
                     <paragraph display-inline="no-display-inline"
                                id="H9A79C70FB28C4D90B4D00CFD04A62793"
                                qb-display-quote="yes">
                        (2)
                        in subparagraph (D), by striking the period and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">; and; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H575C257A9F8448638C73331155659521"
                                qb-display-quote="yes">
                        (3)
                        by adding at the end the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H952A69C5803646EDB6E18C557708FAE6"
                                      style="OLC">
                           <subparagraph display-inline="no-display-inline"
                                         id="H9645CD0FDDF8466E9F6CF2B4CA87FCA1"
                                         qb-display-quote="yes">
                              (E)
                              $19,726,027 for the period beginning on October 1,
                                            2023, and ending on November 17, 2023, to remain
                                            available until expended.
                           
                           .
                        
                     
                  
                  <subsection display-inline="no-display-inline"
                              id="H4E309C49735D44408A87A52C310F0940"
                              qb-display-quote="yes">
                     (b)
                     Extending funding for special diabetes programs for
                                indians
                     Section 330C(c)(2) of the Public Health Service Act (42 U.S.C.
                                    254c–3(c)(2)) is amended—
                     <paragraph display-inline="no-display-inline"
                                id="HE14A14EF8FC94700852491FC0980009C"
                                qb-display-quote="yes">
                        (1)
                        in subparagraph (C), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and at the
                                    end;
                     
                     <paragraph display-inline="no-display-inline"
                                id="HFD971D8B608F4B20A787BDBB3DF22A00"
                                qb-display-quote="yes">
                        (2)
                        in subparagraph (D), by striking the period and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">; and; and
                     
                     <paragraph display-inline="no-display-inline"
                                id="H6F98650AFA534EAEACB0580AEEAF1EA7"
                                qb-display-quote="yes">
                        (3)
                        by adding at the end the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H79E6E932F619431499DDB7B25DB96DFD"
                                      style="OLC">
                           <subparagraph display-inline="no-display-inline"
                                         id="H3ACA2D387D7E4A9AA1C1ADC324DCBD31"
                                         qb-display-quote="yes">
                              (E)
                              $19,726,027 for the period beginning on October 1,
                                            2023, and ending on November 17, 2023, to remain
                                            available until expended.
                           
                           .
                        
                     
                  
               
            
            <subtitle id="H2A9F00061A6442668CB85A6811F9D0FC"
                      qb-display-quote="yes"
                      style="OLC">
               C
               Necessary Authorities To Respond to Threats
               <section display-inline="no-display-inline"
                        id="H21C9883264CB49779B2A8E1451617186"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2331.
                  EXTENSION OF AUTHORITY TO MAKE CERTAIN APPOINTMENTS OF NATIONAL
                            DISASTER MEDICAL SYSTEM PERSONNEL
                  Section 2812(c)(4)(B) of the Public
                            Health Service Act (42
                                U.S.C. 300hh–11(c)(4)(B)) is amended by striking
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">September 30, 2023 and inserting <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">November 17,
                                2023.
                  
                     137 STAT. 96
                  
               
               <section display-inline="no-display-inline"
                        id="HB14ED4085AFE4F4FBDA2892571C3DA70"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2332.
                  TEMPORARY REASSIGNMENT OF STATE AND LOCAL PERSONNEL DURING A PUBLIC
                            HEALTH EMERGENCY
                  Section 319(e)(8) of the Public
                            Health Service Act (42
                                U.S.C. 247d(e)(8)) is amended by striking <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">September
                                30, 2023 and inserting <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">November 17,
                            2023.
               
               <section display-inline="no-display-inline"
                        id="H5658294DA06D4AEBBC04E3C7B645EA76"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2333.
                  EXTENSION OF NATIONAL ADVISORY COMMITTEES
                  <subsection display-inline="no-display-inline"
                              id="H186547EDE807440DBC12689F03B8178E"
                              qb-display-quote="yes">
                     (a)
                     National advisory committee on children and disasters
                     Section 2811A(g) of the Public Health Service Act (42 U.S.C.
                                300hh–10b(g)) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30,
                                    2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">November 17,
                                2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="H6BCFD0433D7F465885A2D5BCA018869A"
                              qb-display-quote="yes">
                     (b)
                     National advisory committee on seniors and disasters
                     Section 2811B(g)(1) of the Public Health Service Act (42 U.S.C.
                                300hh–10c(g)(1)) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30,
                                    2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">November 17,
                                2023.
                  
                  <subsection display-inline="no-display-inline"
                              id="HF67656EA00E445BF9C4CBB57BD9E706F"
                              qb-display-quote="yes">
                     (c)
                     National advisory committee on individuals with disabilities and
                                disasters
                     Section 2811C(g)(1) of the Public Health Service Act (42 U.S.C.
                                300hh–10d(g)(1)) is amended by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">September 30,
                                    2023 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">November 17,
                                2023.
                  
               
            
            <subtitle id="H05E71FD3CCB14424B00F9A321F1E0E8A"
                      qb-display-quote="yes"
                      style="OLC">
               D
               Medicaid
               <section display-inline="no-display-inline"
                        id="HF0A75405EADE443EBED77CF092691204"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2341.
                  DSH DELAY
                  
                     Time periods.
                  
                  Section 1923(f)(7)(A) of the Social
                            Security Act (42 U.S.C.
                                1396r–4(f)(7)(A)) is amended—
                  <paragraph display-inline="no-display-inline"
                             id="H3F973B4FDEB141B0B1D4624B80171C6E"
                             qb-display-quote="yes">
                     (1)
                     in clause (i)—
                     <subparagraph display-inline="no-display-inline"
                                   id="HC1C51C3465F44D7CA15FBF7F9B217A05"
                                   qb-display-quote="yes">
                        (A)
                        in the matter preceding subclause (I), by striking <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">For
                                        each of fiscal years 2024 through 2027 and inserting
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">For the period beginning November 18, 2023, and
                                        ending September 30, 2024, and for each of fiscal years 2025
                                        through 2027; and
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="HB0CDEDB581684EAF81BB0FE50E1CF978"
                                   qb-display-quote="yes">
                        (B)
                        in subclauses (I) and (II), by inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">or
                                        period after <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">the fiscal year each
                                    place it appears; and
                     
                  
                  <paragraph display-inline="no-display-inline"
                             id="HB5DD8FF41AAB45A4A438E972CC139795"
                             qb-display-quote="yes">
                     (2)
                     in clause (ii), by striking <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">for each of fiscal years 2024
                                    through 2027 and inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">for the period
                                    beginning November 18, 2023, and ending September 30, 2024, and
                                    for each of fiscal years 2025 through 2027..
                  
               
               <section display-inline="no-display-inline"
                        id="H9697617518804B4980B2DB496232341D"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2342.
                  MIF REDUCTION
                  Section 1941(b)(3)(A) of the Social
                            Security Act (42 U.S.C.
                                1396w–1(b)(3)(A)) is amended by striking
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">$7,000,000,000 and inserting
                                <quote quote-display-end="auto"
                            quote-display-start="auto"
                            quote-type="text">$6,357,117,810.
               
            
            <subtitle id="H3F81FB060DC14824945B4B281C9AEA17"
                      qb-display-quote="yes"
                      style="OLC">
               E
               Human Services
               <section display-inline="no-display-inline"
                        id="HC8698ADC4E8D4081B882879C9EBF2924"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2351.
                  EXTENSION OF CHILD AND FAMILY SERVICES PROGRAMS
                  Activities authorized by part B of
                            title IV of the Social Security Act shall continue through November 17,
                            2023, in the manner authorized for fiscal year 2023, and out of any
                            money in the Treasury of the United States not otherwise appropriated,
                            there are hereby appropriated such sums as may be necessary for such
                            purpose.
               
               <section display-inline="no-display-inline"
                        id="H3B195A4B90E0468DA83EA9F127810390"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2352.
                  SEXUAL RISK AVOIDANCE EDUCATION EXTENSION
                  Section 510 of the Social Security
                            Act (42 U.S.C.
                            710) 
                        137 STAT.
                                    97
                      is amended—
                  <paragraph display-inline="no-display-inline"
                             id="H005EC928A60449068A8E145C1DE0F068"
                             qb-display-quote="yes">
                     (1)
                     in subsection (a)—
                     <subparagraph display-inline="no-display-inline"
                                   id="H8A7F52405DEA48FDB0151A5B62ED28D1"
                                   qb-display-quote="yes">
                        (A)
                        in paragraph (1)—
                        <clause display-inline="no-display-inline"
                                id="H64DC416BEF4048FD98FA05736D05E4A1"
                                qb-display-quote="yes">
                           (i)
                           in the matter preceding subparagraph (A)—
                           <subclause display-inline="no-display-inline"
                                      id="HB27F526859304697A1334F13FCE0C976"
                                      qb-display-quote="yes">
                              (I)
                              by inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">and for the period beginning on
                                                October 1, 2023, and ending on November 17,
                                                2023 after <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2023; and
                           
                           <subclause display-inline="no-display-inline"
                                      id="HD58B064BAFE84E9FB63F477127987E48"
                                      qb-display-quote="yes">
                              (II)
                              by inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">(or, with respect to such period,
                                                for fiscal year 2024) after <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">for the
                                                fiscal year; and
                           
                        
                        <clause display-inline="no-display-inline"
                                id="H22E2F9DE60F245BE82EC97F1F86F8072"
                                qb-display-quote="yes">
                           (ii)
                           in subparagraph (A), by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">or period
                                        after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">fiscal year each place it appears;
                                        and
                        
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="H7EE252AEDD804791B6CA738321B9CC09"
                                   qb-display-quote="yes">
                        (B)
                        in paragraph (2)—
                        <clause display-inline="no-display-inline"
                                id="H72527888052C47A9B2D1ABEB10CFE0CF"
                                qb-display-quote="yes">
                           (i)
                           in subparagraph (A), by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">and with respect
                                            to fiscal year 2024, for the period described in
                                            paragraph (1) after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">2023;
                                        and
                        
                        <clause display-inline="no-display-inline"
                                id="H07CA6EAF9DE248C7ABF483ABA8CD1460"
                                qb-display-quote="yes">
                           (ii)
                           in subparagraph (B)(i), by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">(or, with
                                            respect to fiscal year 2024, for the period described in
                                            paragraph (1)) after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">for the fiscal
                                            year; and
                        
                     
                  
                  <paragraph display-inline="no-display-inline"
                             id="HD023A6B2E01044D7BF3C7E94C85B14F3"
                             qb-display-quote="yes">
                     (2)
                     in subsection (f)—
                     <subparagraph display-inline="no-display-inline"
                                   id="HB07511F60E624BF7A5B7FFD24651B222"
                                   qb-display-quote="yes">
                        (A)
                        in paragraph (1), by inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">, and for the period
                                        beginning on October 1, 2023, and ending on November 17,
                                        2023, an amount equal to the pro rata portion of the amount
                                        appropriated for the corresponding period for fiscal year
                                        2023 after <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2023; and
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="H8959D9B181CD44109330A58941917470"
                                   qb-display-quote="yes">
                        (B)
                        in paragraph (2), by inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">and for the period
                                        described in paragraph (1), after
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">2023,.
                     
                  
               
               <section display-inline="no-display-inline"
                        id="HE022B72198DD46E2B0F4CA85644DB824"
                        qb-display-quote="yes"
                        section-type="subsequent-section">
                  2353.
                  PERSONAL RESPONSIBILITY EDUCATION EXTENSION
                  Section 513 of the Social Security
                            Act (42 U.S.C.
                            713) is amended—
                  <paragraph display-inline="no-display-inline"
                             id="HD34D4A5A1527414C978252F25F69EDD7"
                             qb-display-quote="yes">
                     (1)
                     in subsection (a)—
                     <subparagraph display-inline="no-display-inline"
                                   id="HD41E27A7505441E9855B7AE7D26EA62E"
                                   qb-display-quote="yes">
                        (A)
                        in paragraph (1)—
                        <clause display-inline="no-display-inline"
                                id="H327182B7E08F4647834EFA0F115B9562"
                                qb-display-quote="yes">
                           (i)
                           in subparagraph (A)—
                           <subclause display-inline="no-display-inline"
                                      id="H1EFFFA9B14ED40989BEAD785CE2FD85D"
                                      qb-display-quote="yes">
                              (I)
                              in the matter preceding clause (i), by inserting
                                                <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">and for the period beginning on October 1,
                                                2023, and ending on November 17, 2023 after
                                                <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">2023; and
                           
                           <subclause display-inline="no-display-inline"
                                      id="H1E01324E1D114F6AA0C737C95CC4F56F"
                                      qb-display-quote="yes">
                              (II)
                              in clause (i), by inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">or period
                                            after <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">for the fiscal year;
                           
                        
                        <clause display-inline="no-display-inline"
                                id="HD5AEB417D7EC40C192F1F618EA42D995"
                                qb-display-quote="yes">
                           (ii)
                           in subparagraph (B)(i), by inserting the following after
                                        the period: <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">The previous sentence shall not apply
                                            with respect to State allotments under this paragraph
                                            for the period beginning on October 1, 2023, and ending
                                            on November 17, 2023.; and
                        
                        <clause display-inline="no-display-inline"
                                id="H88BFB42A8A8D4312AA0D35150B138F8A"
                                qb-display-quote="yes">
                           (iii)
                           in subparagraph (C)(i)—
                           <subclause display-inline="no-display-inline"
                                      id="HA46C0339CDB3456A922D6F625576DE25"
                                      qb-display-quote="yes">
                              (I)
                              by inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">or the period described in
                                                subparagraph (A) after <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">for a fiscal
                                                year; and
                           
                           <subclause display-inline="no-display-inline"
                                      id="H6BD69110B8844F8C8146A5FCC2694BA4"
                                      qb-display-quote="yes">
                              (II)
                              by inserting <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">or period after <quote quote-display-end="auto"
                                        quote-display-start="auto"
                                        quote-type="text">the
                                                fiscal year;
                           
                        
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="H3D92B81BFA1D4E10BD7AA5A131275EB3"
                                   qb-display-quote="yes">
                        (B)
                        in paragraph (3)—
                        <clause display-inline="no-display-inline"
                                id="HF8B36A4C83C541B8859F3341E912A267"
                                qb-display-quote="yes">
                           (i)
                           by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">or the period described in paragraph
                                            (1)(A) after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">for a fiscal year;
                                        and
                        
                        <clause display-inline="no-display-inline"
                                id="H63FCCE04CE4047D3AAB2A0F466086B20"
                                qb-display-quote="yes">
                           (ii)
                           by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">or period after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">such
                                            fiscal year; and
                        
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="HBE1EFB0C01EB43BCB8EEA9D315640975"
                                   qb-display-quote="yes">
                        (C)
                        in paragraph (4)—
                        
                           137 STAT. 98
                        
                        <clause display-inline="no-display-inline"
                                id="HC0FA890B98744D01A12EDBC7ECF14856"
                                qb-display-quote="yes">
                           (i)
                           by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">and for the period described in
                                            paragraph (1)(A) after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">fiscal years 2010
                                            through 2023;
                        
                        <clause display-inline="no-display-inline"
                                id="H349D0A02D3C24759950542B6EEBDBC72"
                                qb-display-quote="yes">
                           (ii)
                           by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">and for the period so
                                            described after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">fiscal years 2012 through
                                            2023; and
                        
                        <clause display-inline="no-display-inline"
                                id="H51412D8F620E421D957EE44CA1461A42"
                                qb-display-quote="yes">
                           (iii)
                           by inserting <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">or the period so described
                                        after <quote quote-display-end="auto"
                                     quote-display-start="auto"
                                     quote-type="text">for a fiscal year;
                        
                     
                  
                  <paragraph display-inline="no-display-inline"
                             id="HEC877F43A1724C30B9435E7805277460"
                             qb-display-quote="yes">
                     (2)
                     in subsection (c)—
                     <subparagraph display-inline="no-display-inline"
                                   id="H98AD3E754AD14759914A37643DD34A04"
                                   qb-display-quote="yes">
                        (A)
                        in each of paragraphs (1) and (2), by striking
                                        <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">From and inserting <quote quote-display-end="auto"
                                  quote-display-start="auto"
                                  quote-type="text">Subject to
                                        paragraph (3), from; and
                     
                     <subparagraph display-inline="no-display-inline"
                                   id="H8E968C50664F49C4B620BCE1D253B88E"
                                   qb-display-quote="yes">
                        (B)
                        by adding at the end the following:
                        <quoted-block display-end-quotes="yes"
                                      display-inline="no-display-inline"
                                      display-quotes="yes"
                                      id="H80D2E6ECE82F4F0092EFB7DE3716B185"
                                      style="OLC">
                           <paragraph display-inline="no-display-inline"
                                      id="H789C1F897BD044A2A23CB55E47C0BDD9"
                                      qb-display-quote="yes">
                              (3)
                              Exception
                              Paragraphs (1) and (2) shall not apply with respect to
                                            any amount appropriated under subsection (f) for the
                                            period described in subsection (a)(1)(A).
                           
                           ; and
                        
                     
                  
                  <paragraph display-inline="no-display-inline"
                             id="HEFF9F03010AF4FB7A232C7729A9AED78"
                             qb-display-quote="yes">
                     (3)
                     in subsection (f), by inserting <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">, and for the period
                                    beginning on October 1, 2023, and ending on November 17, 2023,
                                    an amount equal to the pro rata portion of the amount
                                    appropriated for the corresponding period for fiscal year
                                    2023 after <quote quote-display-end="auto"
                               quote-display-start="auto"
                               quote-type="text">2023.
                  
               
            
         
         <title id="H95ADBBC7F730494986AA65D982E8555C"
                qb-display-quote="yes"
                style="OLC">
            IV
            BUDGETARY EFFECTS
            <section display-inline="no-display-inline"
                     id="HA0BAEC9993984F31AF7E2CCF95D99364"
                     qb-display-quote="yes"
                     section-type="subsequent-section">
               2401.
               BUDGETARY EFFECTS
               <subsection display-inline="no-display-inline"
                           id="HDAAEBCA5BADD4E09A8648A1B2A2283A1"
                           qb-display-quote="yes">
                  (a)
                  Statutory paygo scorecards
                  The budgetary effects of this division shall not be entered on either
                            PAYGO scorecard maintained pursuant to section 4(d) of the Statutory
                            Pay-As-You-Go Act of 2010.
               
               <subsection display-inline="no-display-inline"
                           id="H4315C50ADFFF4A689AE38B8037209944"
                           qb-display-quote="yes">
                  (b)
                  Senate paygo scorecards
                  The budgetary effects of this division shall not be entered on any
                            PAYGO scorecard maintained for purposes of section 4106 of H. Con. Res.
                            71 (115th Congress).
               
               <subsection display-inline="no-display-inline"
                           id="H2D99A37B9E9245CD96C6744E97F81BC5"
                           qb-display-quote="yes">
                  (c)
                  Classification of budgetary effects
                  Notwithstanding Rule 3 of the Budget Scorekeeping Guidelines set forth
                            in the joint explanatory statement of the committee of conference
                            accompanying Conference Report 105–217 and section 250(c)(8) of the
                            Balanced Budget and Emergency Deficit Control Act of 1985, the budgetary
                            effects of this division shall not be estimated—
                  <paragraph display-inline="no-display-inline"
                             id="HA0D7FC45595F4E518319A7F32AB567A2"
                             qb-display-quote="yes">
                     (1)
                     for purposes of section 251 of such Act;
                  
                  <paragraph display-inline="no-display-inline"
                             id="H8A7929111982478B82DD3A0A1F69A088"
                             qb-display-quote="yes">
                     (2)
                     for purposes of an allocation to the Committee on Appropriations
                                pursuant to section 302(a) of the Congressional Budget Act of 1974;
                                and
                  
                  <paragraph display-inline="no-display-inline"
                             id="H3A817267F2A64603AB7C5FCBB5C9739B"
                             qb-display-quote="yes">
                     
                        137 STAT.
                                99
                     
                     (3)
                     for purposes of paragraph (4)(C) of section 3 of the Statutory
                                Pay-As-You-Go Act of 2010 as being included in an appropriation
                                Act.
                  
               
            
         
      
   
   Approved September 30, 2023.
   
      
         
            H.R. 5860
         
      
      
         Sept. 30, considered and passed House and
                Senate.
      
   

